Professional Documents
Culture Documents
Book of Abstracts
Book of Abstracts
(POGS)
2021 Annual Convention and 75th Diamond Anniversary Celebration
“#RISE Up to the New Normal: Relevant, Innovative, Sensitive, Engaging”
BOOK OF ABSTRACTS
2021
Members
Joanne Karen S. Aguinaldo, MD
Mikaela Erlinda M. Bucu, MD
Mary Judith Q. Clemente, MD
Ma. Febi B. De Ramos, MD
Sherri Ann L. Suplido, MD
Technical Secretary
Ms. Mary Rose P. Guinto
Philippine Obstetrical and Gynecological Society (Foundation), Inc. (POGS)
Board of Trustees 2021
Benjamin D. Cuenca, MD
President
Marlyn T. Dee, MD
Vice President
Leilani C. Coloma, MD
Secretary
Erwin R. De Mesa, MD
Treasurer
Board of Trustees
Rowena M. Auxillos, MD
Efren J. Domingo, MD
Pressie P. Eclarin, MD
Ma. Gay M. Gonzales, MD
Gil G. Gonzales, MD
Henrietta S. Lucasan, MD
Annette M. Macayaon, MD
Enrico Gil C. Oblepias, MD
Marjorie I. Santos, MD
Ronaldo Antonio R. Santos, MD
Philippine Obstetrical and Gynecological Society (Foundation), Inc. (POGS)
2021 Annual Convention and 75th Diamond Anniversary Celebration
“#RISE Up to the New Normal: Relevant, Innovative, Sensitive, Engaging”
Officers
POGS President and Honorary Chair Benjamin D. Cuenca, MD
POGS Vice President and Overall Chair Marlyn T. Dee, MD
POGS Board Secretary Leilani C. Coloma, MD
Convention Secretary Catherine Joie Carelle R. Ong, MD
POGS Treasurer Erwin E. De Mesa, MD
POGS Public Relations Officer Ma. Socorro M. Solis, MD
Committees
Scientific Program Angela S. Aguilar, MD
Ma. Cristina P. Crisologo, MD
Speaker’s Bureau Jocelyn Z. Mariano, MD
Katherine A. Dela Cruz, MD
E-Library Anne Catherine A. Castro, MD
Andrea S. Santiago, MD
Virtual Arrangements and Jennifer T. Go, MD
Technical Systems (VART) Marlene R. Javier, MD
Ways and Means Ditas Christina D. Decena, MD
Sybil Lizanne R. Bravo, MD
Exhibits Rosemarie P. Tiburcio, MD
Kristen C. Canlas, MD
Documentation Leslie R. Rigor, MD
Leedah L. Rañola-Nisperos, MD
Programs and Invitations Anne Marie C. Trinidad, MD
Maria Therese B. Mallen, MD
Souvenir Program Maria Lyn E. Sese, MD
Rosa P. Capinpin, MD
Scientific Work Abstracts Ana Victoria V. Dy Echo, MD
Maria Constancia Y. Wylengco, MD
Registration Emmanuel L. Dagala, MD
Maribel Emma C. Hidalgo, MD
Socials Jennifer A. Aranzamendez, MD
Marinella Agnes G. Abat, MD
Sports Antoinette U. Añonuevo, MD
Marinella Agnes G. Abat, MD
Table of Contents
RESEARCH
R-1 A comparative study on the use of Friedman’s curve Lara Germaine Q. Torres-Gongora, MD
vs. Zhang partogram on maternal and neonatal Andrea Milagros L. Mapili, MD
outcomes in a tertiary hospital: A cross-sectional
study
R-5 Association of total gestational weight gain and Francesca Debbie L. Liu, MD
maternal and perinatal outcomes among pregnant Maria Michelle G. Borbe, MD
patients using the Institute of Medicine 2009
gestational weight gain guidelines in a tertiary
hospital
R-6 Changes in obstetric practices in the first 3 months Kristine Mae A. de Guzman, MD
of the COVID-19 pandemic in a private tertiary Agnes L. Soriano-Estrella, MD, MHPEd
hospital: A descriptive cross-sectional study
R-11 Effect of the COVID-19 pandemic on utilization of Maria Stephanie Fay S. Cagayan, MD, PhD
Luzon rural health units BEmONC facilities Mary Christine R. Castro, MD
Gene A. Nisperos, MD
R-19 Patient and operative factors associated with Iza Roelle L. Maniego, MD
strategic or reactive conversion to laparotomy Prudence V. Aquino-Aquino, MD
during laparoscopy in pelvic endometriosis: A case- Maria Rica F. Arandia-Baltazar, MD
control study Zoraida R. Umipig-Guevara, MD
R-22 Preterm birth research in Southeast Asia and its Koleen C. Pasamba, MD
association with socioeconomic determinants and Jean Anne B. Toral, MD, MSc
burden of disease: A bibliometric analysis
R-23 Prevalence of mismatch repair deficiency in Filipino Maria Patricia Angelica M. Tanchuling, MD
women with endometrial cancer and its correlation Michelle H. Diwa, MD
with clinicopathologic features, adjuvant treatment Karen Cybelle J. Sotalbo, MD
and outcomes Cecile C. Dungog, MD, PhD
Renee Vina G. Sicam, MD
Carolyn R. Zalameda-Castro, MD, MSc
RCH
INTERESTING CASE
IC-1 A case of complex diagnosis and management of Ashley Ediamy D. Go, MD
obstetrically acquired hemophilia Maynila E. Domingo, MD
IC-8 Avascular necrosis of the femoral head in a 22-year Hannah Shene M. Leong, MD
old with primary amenorrhea Concepcion D. Rayel, MD
Irene L. Uy, MD
IC-10 Case of a 19-year-old with malignant spindle cell Leobert Julienne A. dela Peña, MD
neoplasm; pelvic monophasic synovial sarcoma Ronald Lanz R. Latap, MD
arising from the pelvic soft tissues and ligaments
IC-15 Delayed diagnosis and management of late second Ana Patricia C. Vargas, RCh, MD, MBA
trimester intra-abdominal pregnancy Viktoria Ines P. Matibag, MD
Maria Anna Luisa F. Dalawangbayan, MD
INTERESTING CASE
IC-16 Detour: A case report on advanced abdominal Vivien Jovie A. Mercado, MD
pregnancy Jeejane A. Bonggao, MD
IC-17 Double trouble: A case of symptomatic olfactory Breann Katrina R. Chaplin, MD, MBA
nerve schwannoma diagnosed and managed in the Lyra Ruth C. Chua, MD
third trimester of pregnancy in a Philippine tertiary
hospital
IC-18 Early stage high grade endometrial stromal Renee Leen M. Laudato, MD
sarcoma of the cervix in the young: A case report Carolyn R. Zalameda-Castro, MD, MSc
IC-20 Giant immature teratoma in a 15-year old causing Alfonso Leandro del Rio Toreja, MD
anti-N-methyl-D-aspartate receptor encephalitis-like Angelito D.L. Magno, MD
and Guillain-Barre syndrome as paraneoplastic
manifestations: A case report
IC-22 Herlyn Werner Wunderlich syndrome with an Rochelle Mae M. Supan, RN, MD
incidental finding of unilateral adrenal gland Junette Grace A. Ko, MD
agenesis: A case report
IC-23 Isolated fallopian tube torsion in an early Princess Bianca DL. Palabrica, MD
adolescent: A case report Maria Therese B. Mallen, MD
Germaine Aldrene C. Tan, MD
IC-26 More than teen angst: A case of ovarian teratoma Ma. Rosila Flor DJ. Escudero, MD, MBA
presenting as anti-N-methyl-D-aspartate receptor Lyra Ruth C. Chua, MD
encephalitis
IC-31 Squamous cell carcinoma arising within a mature Inez Jade T. Quial-Riolo, MD
cystic teratoma of the ovary: A report of two cases Raymond S. Sulay, MD
IC-32 Struma ovarii associated with pseudo-Meigs’ Nicole Anna Marie H. Dionisio, MD
syndrome with concomitant abdominopelvic Elizabeth K. Jacinto, MD
tuberculosis masquerading as ovarian malignancy
IC-35 The value of placental cannulation and dye injection Jessica G. De Dios, MD
in unraveling the mystery of a monochorionic twin Kathryn Kristy P. Bautista, MD
pregnancy with coexistent selective intrauterine
growth restriction and twin-to-twin transfusion
syndrome
IC-39 When the metastatic tumor presents as a primary Ma. Rosila Flor DJ. Escudero, MD, MBA
tumor: Gastric signet ring cell carcinoma presenting Angelito D.L. Magno, MD
as advanced cervical cancer with ovarian
metastasis
R-1
Introduction: Friedman’s curve is the gold standard for monitoring the progress of labor. Due to
the gradually increasing prevalence of cesarean delivery and changes in the characteristics of
parturients and labor management, Zhang labor curve progress was conducted to examine
whether the labor curves of parturients today follow the average labor curve constructed by
Friedman. The research aimed to explore whether the Zhang partogram can be used an
alternative tool for monitoring the progress of labor and as a basis for the definitions of
dysfunctional labor.
Objective: To compare the maternal outcome and neonatal outcome among parturients
managed according to Friedman’s curve vs Zhang partogram.
Methodology: This study utilized a cross-sectional design. A total of 179 patients of Baguio
General Hospital and Medical Center were enrolled in this study fulfilling the inclusion and
exclusion criteria. The patients were randomly assigned into either Group A (Friedman Group)
or Group B (Zhang group). Labor progress was plotted against the Friedman or the Zhang
partograph respectively. Chi-square was used to compare the maternal and neonatal outcomes
according to Friedman’s and Zhang partograph.
Results: Of the 179 patients, 89 were assigned in the Friedman group and 90 in the Zhang group.
The demographic data of patients in both groups were comparable. Utilization of the Friedman’s
curve as a basis for management of dysfunctional labor was associated with a higher incidence
of primary cesarean section (30 vs. 11, p=0.0006) and post-operative infection (11 vs. 2, p=0.008).
There was no difference in the incidence of hemorrhage (2 vs. 0, p=0.246) and atony (1 vs. 0,
p=0.497) in both groups. There was no significant difference in neonatal outcomes in both
groups.
Conclusion: The rate of primary cesarean section for dysfunctional labor was significantly higher
if labor progression was based on the Friedman’s curve as compared to the Zhang model without
any significant difference in the neonatal outcome.
Bernadette Mayumi T. Mortel, MD, Lilli May T. Cole, MD, FPOGS, FPSGOP,
Debby P. Songco, MD, FPOGS, FPSRM, Arnel C. Dy, MD
University of the East – Ramon Magsaysay Memorial Medical Center, Inc.
Introduction: Abnormal uterine bleeding (AUB) and postmenopausal bleeding (PMB) are
healthcare burdens constituting majority of gynecologic consults. As these are primary
manifestations of benign and malignant endometrial lesions, evaluation through endometrial
sampling is crucial in early diagnosis and disease prevention. Hysteroscopy, the gold standard in
endometrial evaluation, is often unavailable in low-resource settings. Also, available outpatient
devices like the Pipelle, may yield insufficient samples affecting diagnostic accuracy. Improved
variations, like the endosampler, are reported to obtain more tissues. Additionally, the World
Health Organization (WHO) has recently recommended manual vacuum aspiration (MVA) as an
alternative sampler for its accuracy and cost-effectiveness.
Objective: This study aimed to compare MVA to endosampler in detecting endometrial
pathology among women with AUB or PMB, specifically comparing histopathologic diagnosis,
tissue yield, and pain scores.
Methodology: This cross-sectional diagnostic study was done at a tertiary university hospital
from August 2020 to January 2021. Thirty-one (31) women with AUB or PMB underwent
endometrial sampling using both endosampler and MVA. Participants were randomly divided
into two groups based on treatment sequence. Age, gravidity, and endometrial thickness were
recorded. Histopathologic diagnoses, weight of endometrial tissues, and pain scores by Visual
Analogue Pain Scale (VAPS) were evaluated.
Results: The MVA had high sensitivity and specificity in detecting premalignant and malignant
lesions, with a diagnostic accuracy of 96.7%. There was histopathologic concordance to
endosampler in all cases of hyperplasias and carcinomas. The MVA also detected the following
over endosampler: 1 hyperplasia without atypia, 1 atypical hyperplasia, 1 endometrial
carcinoma, 1 leiomyoma, and 1 proliferative endometrium. The MVA sampled significantly more
endometrial tissue than endosampler (2.1 g vs 1.5 g, p=0.008). The pain scores for both groups
had no significant difference.
Conclusion: The MVA is comparable to endosampler as an endometrial sampling alternative in
low-resource settings. It yields more endometrial tissues than the endosampler with no
significant difference in pain scores.
Introduction: The diagnostic approach for abnormal uterine bleeding to rule out endometrial
carcinoma is constantly evolving. Sono-elastography is a novel imaging technique that has been
shown to differentiate benign from malignant lesions in other organs but has limited studies in
the field of gynecology.
Objective: To evaluate the diagnostic value of sono-elastography in distinguishing endometrial
cancer from benign endometrial lesions.
Methodology: A cross-sectional study was conducted and included 31 subjects with abnormal
uterine bleeding who required endometrial sampling. Sono-elastography assessment was done
qualitatively and quantitatively using Tsukuba elasticity score and strain ratio, respectively.
Results were compared between those with endometrial cancer and those with benign
endometrial lesions (hyperplasia and polyp) using Kruskal-Wallis test and Mann-Whitney U test.
Diagnostic accuracies of Tsukuba elasticity score and strain ratio in differentiating endometrial
cancer from benign endometrial lesions were determined with cut-off values derived from ROC
analysis.
Results: Both the Tsukuba elasticity score and strain ratio values were significantly higher among
patients with endometrial cancer (n=15; mean age: 55.07 ± 8.53 years) compared to those with
benign endometrial lesions (n=16; mean age: 41.63 ± 8.02 years) (p<0.0001). A Tsukuba elasticity
score of ≥ 3 showed the highest diagnostic accuracy at 93.5% (95% CI 79.3%-98.2%), with
sensitivity of 86.7% (95% CI 62.1%-96.3%), specificity of 100% (95% CI 80.6%-100%), positive
predictive value (PPV) of 100% (95% CI 77.2%-100%), negative predictive value (NPV) of 88.9%
(95% CI 67.2%-96.9%), positive likelihood ratio (LR) of undefined indicating high value, and
negative LR of 0.10 (95% CI 0.05-0.40). A strain ratio value of ≥ 2 showed the highest diagnostic
accuracy at 93.5% (95% CI 79.3%-98.2%), with sensitivity of 93.3% (95% CI 70.2%-98.8%),
specificity of 93.8% (95% CI 71.7%-98.9%), PPV of 93.3% (95% CI 70.2%-98.8%), NPV of 93.8%
(95% CI 71.7%-98.9%), positive LR 14.9 (95% CI 2.1-107.1), and negative LR of 0.07 (95% CI 0.01-
0.51).
Conclusion: The results indicate that sono-elastography can distinguish endometrial cancer from
benign endometrial lesions. However, external validation on a larger scale of population should
be done.
Introduction: The readiness of primary birthing facilities to avert maternal and neonatal
mortalities arise from their capacity to perform signal functions for emergency obstetric and
newborn care.
Objective: This study assessed the functionality of basic emergency obstetric and newborn care
(BEmONC)-capable rural health units (RHUs) in Central Luzon in providing obstetric services from
December 2019 to November 2020. Barriers and facilitators to effectively deliver services were
determined.
Methodology: A mixed method approach was employed for this observational cross-sectional
study. Randomly selected RHUs in 4 representative provinces in Central Luzon known to have
low, medium, and high maternal mortality rates (MMRs) were visited. A scorecard summarizing
points given to infrastructure, personnel, ability to perform signal functions and provision of
maternal health services, all gathered electronically using the BEmONC Functionality Assessment
Toolkit, was used. Focus group discussion of 6 mothers and 15 healthcare personnel was done
virtually to determine their insights on the impact of BEmONC in their community.
Results: A total of 30 RHUs from Aurora, Zambales, Bulacan and Pampanga were visited. Based
on the scorecard, only 7 (23%) facilities were BEmONC-functional and 23 (77%) were not. The
number of facilities which were able to perform selected signal functions during the observation
period are the following: 12 (40%) for antibiotic administration, 9 (30%) for magnesium sulfate
administration, 13 (43.4%) for administration of uterotonics, 15 (50%) for use of partograph and
12 (40%) for performance of newborn resuscitation. Facilitators of facility functionality include
support from the local government units (LGU) and central offices, adequately trained personnel
and intact referral systems. Barriers identified included problems in infrastructure, lack of
medicines, fast turnover of trained personnel, and pandemic-related issues.
Conclusion: Public birthing facilities in selected provinces in Central Luzon are operational
because the physical infrastructure and services are present but fulfilling signal functions remains
limited. Capacity-building measures are needed to ensure effective delivery of services.
Introduction: Obesity carries a worldwide population epidemic rate that affects both genders
especially women, most significantly pregnant women, influencing one’s daily routine and
activities. The proposed guideline is by the Institute of Medicine (IOM) 2009 Gestational Weight
Gain (GWG), by measuring pre-pregnancy Body Mass Index (BMI) category and the World Health
Organization (WHO) BMI Classification for both International and Asian categories.1 This value
can be influenced by demographic status, medical conditions and maternal and fetal adverse
outcomes.
Objective: The study determined the association of total GWG and maternal and perinatal
outcomes based on the IOM 2009 guidelines among pregnant patients in a tertiary hospital.
Methodology: The prospective cohort study included 565 pregnant women from June 1, 2020
to April 30, 2021. BMI at initial prenatal visit < 14 weeks age of gestation (AOG) and upon
admission, birth weight, and co-morbidities were all assessed and recorded. Main outcome
measures were total GWG, perinatal outcomes (small for gestational age [SGA], large for
gestational age [LGA], intrauterine fetal demise [IUFD], admission to the neonatal intensive care
unit [NICU]) and maternal outcomes (gestational diabetes mellitus [GDM], gestational
hypertension, preeclampsia/eclampsia, preterm birth).
Results: The mean BMI was 23.6 kg/m2 and based on BMI classification, 8% were underweight,
while 28.1% and 9% were overweight and obese, respectively. Based on the recommendations
of total GWG on each BMI category, using chi square test, there was significant association of
having excess GWG and inadequate GWG against maternal and perinatal outcomes.
Conclusion: Women having excess or inadequate total GWG has effects on maternal and
perinatal outcomes. Furthermore, women that are classified as overweight and obese on 1st
trimester has higher risk of developing co-morbidities.
Introduction: With the increasing number of COVID positive cases still being reported in the
country, coupled with the possible vulnerability of pregnant patients to the disease, aggressive
measures must be taken by all institutions to ensure safety of the patients.
Objective: This study aimed to determine the clinical profile and pregnancy outcome of patients
who were admitted at a tertiary private hospital in Metro Manila from March 16, 2020 to June
15, 2020 in relation to the protocols that were implemented in response to COVID-19 Pandemic.
Methodology: The protocols and guidelines implemented by the Department of Obstetrics and
Gynecology of a private tertiary hospital in Metro Manila from March 16, 2020 to June 15, 2020
were retrieved. The case record of patients who were admitted and delivered during this period
were retrieved and reviewed for pertinent data, which were recorded in a patient data collection
form.
Results: During the 3-month study period, COVID positive pregnant patients were effectively
separated from COVID negative patients from admission to discharge based on a health
declaration form and universal RT-PCR testing. Discharge was facilitated after 12-48 hours for
uncomplicated deliveries and postpartum follow-up was done via telemedicine.
Conclusion: The separation of COVID positive from COVID negative patients based on symptoms
and RT-PCR results were effective in ensuring the safety of patients.
Introduction: The SARS-CoV-2 pandemic has had profound effects globally. Previous
coronaviruses have shown increased maternal and perinatal morbidity and mortality,
theoretically secondary to the physiologic changes of pregnancy. As of August 2021, the
Philippines is the 23rd top country worldwide in terms of total cases, yet there remains to be a
sparse pool of information both internationally and locally.
Objective: This study aimed to present the prevalence, clinical characteristics, as well as the
neonatal, obstetric, and maternal outcomes of all pregnant women admitted in a private tertiary
hospital who had active or previous COVID-19 infection.
Methodology: Retrospective review of data using the hospital’s health information system was
utilized. Within the study period, all admitted obstetric patients who had at least one positive
result in an RT-PCR naso-oropharyngeal swab for SARS-CoV-2 were included and categorized into:
(1) symptomatic, (2) recovered, or (3) asymptomatic.
Results: A total of 48 patients were included, where prevalence of COVID-19 in pregnancy was
3.65%. Results showed that most patients were in the third trimester (mean age of gestation
35.26 + 6.39), and contrary to the non-pregnant population, majority (29, 60.41%) did not have
co-morbidities. Most remained asymptomatic (16, 33.33%) or had mild symptoms (9, 18.75%),
and underwent abdominal delivery (23, 47.91%) for obstetric indications. There was one
mortality, who had developed critical severity. COVID-19 status was not associated with adverse
obstetric outcomes in this study population, but had significant association with preterm birth
(p=0.019) and neonatal intensive care unit (NICU) admission (p<0.001).
Conclusion: Overall, most cases of COVID-19 in pregnancy were asymptomatic and had good
prognosis even with the adaptations a pregnant woman undergoes. In addition, neonatal
outcomes were generally good regardless of the association with preterm birth and NICU
admission. Lastly, there was no appreciated evidence for vertical transmission.
Introduction: Vulvovaginal candidiasis (VVC) is one of the frequent infections of the female
genital tract and is the second most common cause of vaginal infections after bacterial vaginosis.
According to the Center for Disease Control and Prevention (CDC), azoles are the first-line of
treatment for VVC. Among the azoles available in the Philippines, only miconazole and
clotrimazole are recommended for both pregnant and non-pregnant women.
Objective: The objective of this study is to compare the effect of miconazole vs. clotrimazole in
the treatment of VVC among patients seen at the outpatient department in a tertiary hospital.
Methodology: This study reviewed a total of 316 records of patients, regardless of pregnancy
status who were given either single dose 1200 mg miconazole or a 6-day 100 mg clotrimazole
vaginal suppository as treatment for VVC.
Results: Among women whose chart records were included, there were 161 (50.94%) who used
miconazole while 155 (49.05%) took clotrimazole. All 316 women included in the study presented
with signs and symptoms of VVC. The most common of which is curd-like vaginal discharge
(86.7%), followed by vulvar pruritus (80.7%), vulvar erythema (50.6%), and the least occurring is
dyspareunia (0.94%). When the signs and symptoms were individually compared between the
two treatment arms, no statistically significant differences were noted. Upon follow- up, 11 out
of 316 (3.46%) were still symptomatic which was noted in 2 (18.1%) from the miconazole group
while 9 (81.8%) from the clotrimazole group. The difference for these outcome between the
treatment groups is statistically significant. With regards to treatment failure rate, for
miconazole it is 1.2% (2/161) while for clotrimazole, it is 5.8% (9/155). None of the charts of these
women had recorded adverse reaction to the given treatment.
Conclusion: Single-dose miconazole regimen has a significantly higher clinical cure rate than the
6-day clotrimazole. It has the potential to improve patient compliance and improve treatment
outcome at a lower cost.
Introduction: The Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by novel
coronavirus named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Its growing
number of cases with a very limited number of studies in the country is quite alarming, especially
to the vulnerable populations, such as pregnant women.
Objective: To determine and compare the maternal and neonatal outcomes of COVID-19 positive
vs. negative parturient.
Methodology: This is a retrospective cohort study of 131 parturient in a tertiary hospital.
Results: The study analyzed a total of 131 patients, of whom 65 (49.6%) were COVID-19 positive.
At the time of testing, more than half were at their early term of pregnancy (64.89%) and at term
(14.5%). Based on disease severity, 45 (69.2%) women exhibited mild disease, 39 were
asymptomatic and 6 symptomatic, 19 (29.2%) moderate disease and 1 (1.5%) severe disease.
Among those symptomatic, the most common signs and symptoms were cough (33.85%),
myalgia (10.77%), and a radiographic finding of localized or multilobar infiltrates (30.76%). Those
who had laboratory exams, the c-reactive protein and D-dimer were found to be elevated. Based
on maternal outcomes, there was higher incidence of preterm birth (21.54%, p=0.048) and longer
length of hospital stay (p=0.005) in the COVID-19 positive group. The neonatal outcomes were
similar in both groups, except for longer hospital stay, and delayed institution of breastfeeding
among the COVID-19 positive group.
Conclusion: In this study, there was no evidence that the presence of COVID-19 infection during
pregnancy causes increased morbidity and mortality in mothers and their neonates. Close
surveillance should be done on this population, especially if detected prior to term, as these
patients are predisposed to having preterm labor. Further research is needed to understand the
true extent of the risks to improve management of these special population.
Introduction: Ovarian, fallopian tube and peritoneal cancer patients with advanced stage at
diagnosis or recurrences spread to the peritoneal surface of the abdomen. Hyperthermic
intraperitoneal chemotherapy (HIPEC) can penetrate and eradicate tumors up to a diameter of
2.5 cm and microscopic disease from the peritoneal surface after cytoreductive surgery (CRS).
Objective: The study aimed to determine the efficacy and safety of CRS with HIPEC vs CRS alone
for patients with epithelial ovarian, fallopian tube and peritoneal cancer.
Methodology: This retrospective cohort study included 50 patients (20 patients who underwent
CRS with HIPEC, and 30 patients who underwent CRS alone). Records of these patients from 2014-
2020 were reviewed and tabulated.
Results: Recurrence rate between patients who underwent CRS with HIPEC and CRS alone was
not statistically significant (50% vs. 43%, p=0.774). Median time to recurrence was 10 and 9
months, respectively (p=0.636). One patient (5%) expired in the CRS with HIPEC group, and 4
patients (13%) expired in the CRS alone (p=0.636). More postoperative complications were noted
in the CRS with HIPEC group (9 vs. 3, p=0.007), but only 2 cases had grade 3 to 4 complications
(10%). CRS with HIPEC patients had longer operative time (360 vs. 240 minutes, p<0.001) and
post-operative hospital stay (8 vs. 6 days, p=0.026). There were no intra- or perioperative
mortalities in both groups.
Conclusion: CRS with HIPEC and CRS alone showed similar time to recurrence and recurrence
rate. CRS with HIPEC had low risk of grade 3-4 complications and may still be considered as a
treatment option for advanced and recurrent epithelial ovarian, fallopian tube and peritoneal
cancer.
Keywords: cytoreductive surgery, HIPEC, ovarian, fallopian tube and peritoneal cancer
R-11
Maria Stephanie Fay S. Cagayan, MD, PhD, FPOGS, FPSSTD, Mary Christine R.
Castro, MD, Gene A. Nisperos, MD
Perinatal Association of the Philippines
Introduction: The entire island of Luzon was placed under Enhanced Community Quarantine
(ECQ) last March 16, 2020, limiting population mobility and access to health facilities in eight
regions. Local government units offer Basic Emergency Obstetric Newborn (BEmONC) services,
including delivery of low-risk pregnancies in their rural health units (RHUs) or city health offices
(CHOs).
Objective: This study determined the effect of the COVID-19 pandemic and quarantine restriction
on the number of deliveries and utilization of RHU BEmONC facilities in Luzon.
Methodology: The number of total monthly deliveries of 245 randomly selected BEmONC-
provider RHUs in Luzon was collected from BEmONC registries covering the period December
2019 to November 2020. An interrupted time series analysis was conducted for aggregated data
per region and for the entire Luzon. Focus groups discussions among 102 healthcare providers
and 98 mothers were conducted to provide insights on the effect of the pandemic and the
quarantine on healthcare accessibility.
Results: There were significant increases in the number of monthly deliveries during the
quarantine in Regions 1, 3, 4A, and 5 due to fear of going to hospitals because of COVID-19.
However, Regions NCR, CAR, and MIMAROPA had a high proportion of non-functional BEmONC
RHUs due to COVID-19 and recent calamities, or because these RHUs were converted to COVID-
19 facilities and therefore could no longer offer BEmONC services. In Regions 1, 5, and
MIMAROPA, BEmONC RHUs had to provide other services, especially to non-COVID-19 patients,
as other facilities were converted to focus on COVID-19 patients. The effect of seasonality on
total deliveries was not determined.
Conclusion: During the pandemic, BEmONC RHUs catered to additional patients. Decreased
access to facilities for non-COVID-19 patients, as well as fear of contracting COVID-19 in hospitals
are intervening factors. Strengthening primary care services can be an integral part of the COVID-
19 pandemic response.
Christine Mariz T. Ching, MD, Maria Michelle G. Borbe, MD, FPOGS, FPSUOG
Chinese General Hospital and Medical Center
Introduction: The emergence of COVID-19 pandemic has left the vulnerable members of the
society at risk, most especially the pregnant women. This event has caused anxieties on their
pregnancy journey. Their main concerns are the effects and transmissibility of the infection to
them and to their unborn child. COVID-19 significantly affects their mental health status.
Objective: The study determined the fears, perceptions and common concerns of pregnant
women during COVID-19 in a tertiary hospital in Manila.
Methodology: This is a prospective, cross-sectional study that used a pretested and validated
questionnaire, which directly asked the fears, perceptions and common concerns on COVID-19
among pregnant women. The survey proper was conducted among 313 singleton, term pregnant
women, aged 18 years old and above.
Results: The analysis included 313 respondents with a mean (±SD) age of 31 ± 6 years. The three
most common fears relayed by the pregnant women were: (1) losing their babies if they get
COVID-19 (67.41%), (2) dying if they get the infection (58.79%), and (3) getting a positive test
result for COVID-19 (54.95%). Most of these patients (99.04%) were aware of the changes on
their prenatal consultation and health care services. Majority of the participants (53.35%) raised
their concerns on the in-utero transmission of the virus, swabbing of their baby if ever they are
positive (44.41%) and nosocomial COVID infection on their newborn from the hospital personnel
(42.81%).
Conclusion: Fear is a common emotion among pregnant women. With the emergence of COVID-
19 pandemic, it exacerbated their fears and raised concerns on the harmful effects that it may
bring on their well-being and on their unborn child. This pandemic had caused a significant
impact on their mental health.
Joanne Y. Luy, MD, Marie Janice A. Boquiren, MD, FPOGS, FPSRM, FPSGE
Southern Philippines Medical Center
Introduction: Interpregnancy interval (IPI) is the period between termination of one pregnancy
and conception of a subsequent one. IPI allows assessment of future pregnancy complications.
Objective: To determine the association of the different IPI on maternal and neonatal outcomes
in multigravid singleton pregnancies.
Methodology: This was a retrospective cohort study, which included multigravid patients with 2
consecutive singleton pregnancies within January 2016 to December 2020, with the first live birth
delivered via normal spontaneous delivery. A comprehensive chart review was utilized. The
population was divided into short IPI (< 24 months), optimal IPI (24-59 months), long IPI (> 60
months). Maternal outcomes measured included incidence of gestational diabetes mellitus,
hypertension, anemia, placental abnormalities and mode of delivery. Fetal outcomes measured
included Apgar score, Ballard score, birthweight, incidence of congenital anomalies and need for
neonatal intensive care unit (NICU) admission. Demographic data, and maternal and neonatal
outcomes were then compared with the different IPI categories.
Results: From the 289 samples collected, 60 had short, 162 with optimal and 67 had long IPI. IPI
was associated with age (p=0.000) and history of contraception (p=0.008). There was no
significant association with the different IPI categories, and maternal and neonatal outcomes.
Conclusion: There was no significant association between IPI, and maternal and neonatal
outcomes among multigravid singleton pregnant women with two consecutive pregnancies.
Introduction: A non-reassuring fetal heart rate pattern is the leading indication for primary
cesarean section. Most cases are associated with hypertension and pre-labor rupture of
membranes. However, low-risk patients without co-morbidities or identified risk factors come in
third.
Objective: This study aimed to determine the clinical profiles, intraoperative findings and
neonatal outcomes of low-risk patients with term pregnancies who underwent emergency
cesarean section for non-reassuring fetal heart rate pattern in a tertiary hospital in Davao City.
Methodology: A retrospective cross-sectional research was used involving 160 patient records
of low-risk patients who underwent emergency cesarean section for non-reassuring fetal heart
rate patterns.
Results: Majority of patients were 20 – 34 years old (123, 77%), single (112, 70%), primigravid
(99, 62%), college undergraduates (48, 30%), with 5 prenatal check-ups (111, 69%) at health care
centers (96, 61%). A few had vices: smoking (5, 3%), alcohol abuse (5, 3%) and illicit drugs (2, 1%).
Most patients were admitted at 39 - 40 6/7 weeks (96, 60%) in latent phase of labor (82, 51%),
with absent or reduced variability and recurrent variable decelerations (93, 58%), absent nuchal
cord (116, 73%), moderate amount of amniotic fluid (82, 52%) and meconium staining (96, 60%).
There were no cases of congenital anomaly and uterine rupture but with 1 placental abruption.
Most had Apgar scores of 6 or more at the 1st (153, 96%) and 5th minute (158, 99%) of life, Ballard
scores of 37-41 weeks (158, 99%) and birthweights appropriate for gestational age (150, 94%).
All were livebirth deliveries with no neonatal complications.
Conclusion: Livebirth babies with good Apgar scores may be attributed to majority of term and
appropriate for gestational age and/or early intervention by cesarean section. Electronic fetal
monitoring is beneficial in improving fetal outcome but close monitoring and judicious
interpretation are warranted to curb rising cesarean section rates.
Keywords: low-risk pregnancy, emergency cesarean section, non-reassuring fetal heart rate
pattern, intraoperative findings, neonatal outcomes
R-16
Introduction: Teenage pregnancy is currently a significant issue globally. In the Philippines, about
10.7% of births were from those aged 15 to 19 years old.
Objective: This study determined the socio-demographic profile and the level of knowledge,
attitude, and practices of obstetrics and gynecology (OB-GYN) consultants and residents and their
correlation.
Methodology: This descriptive cross-sectional research was conducted using total enumeration.
Data was collected via a modified self-administered online questionnaire by Mustafa & Mirkhan
in 2020 to OB-GYN consultants and residents of Region 7. Data were analyzed using descriptive
statistics, chi square test, and Pearson rho correlation tests.
Results: A total of 99 respondents were included in the study, with 60 consultants and 39
residents. Majority of the respondents (70, 70.71%) have a high level of knowledge towards
teenage pregnancy while almost 30% (n=29) have average or low level of knowledge. More than
half of the respondents (51, 51.52%) have a favorable attitude towards teenage pregnancy while
the rest were neutral about it. Common practices of the respondents include discussing antenatal
results to the pregnant mother, involving the adolescent to prenatal care, and advising about
risk-taking behaviors. However, referring pregnant adolescents to pediatrician and screening for
postpartum depression are uncommon. Knowledge levels of the participants were strongly
correlated with their attitudes (0.44, p=0.00) and practices (0.29, p=0.003). There was no
statistical difference between the attitude of the consultants and residents (p<0.05). However,
the highest frequency of practice was from the general OB-GYN followed by subspecialists then
the residents (p<0.05).
Conclusion: There is adequate knowledge on teenage pregnancy among OB-GYN consultants and
residents in the Central Visayas but interventions geared towards improvement of knowledge
may translate to positive attitudes and better practices. Moreover, the practice of postpartum
depression screening among pregnant teens is highlighted.
Introduction: Closure of wounds to attain an aesthetically pleasing scar has always been
a challenge. There is a continuous search for the optimal way to close surgical wounds.
Objective: To compare octyl cyanoacrylate tissue adhesive and sutures in skin closure of
cesarean section
Methodology: This prospective randomized controlled study was conducted at a tertiary
hospital. Patients were randomized to application of octyl cyanoacrylate tissue adhesive
vs. subcuticular skin closure. Scars were evaluated 6-8 weeks postoperatively using the
Patient and Observer Scar Assessment Scale (POSAS). Skin closure time, wound
complications and provider satisfaction were also compared.
Results: Seventy-nine (79) patients were included in the study, 40 of which were in the
suture arm and 39 in the tissue adhesive arm. Demographic characteristics were similar
in both groups. No significant difference was detected between the suture and tissue
adhesive scores using the POSAS 6-8 weeks after cesarean delivery, at p=0.60 for patients
and p=0.43 for observer. Tissue adhesive recorded significantly faster skin closure time,
but the obstetricians involved in the study were more satisfied with using suture for skin
closure. No significant differences in wound disruption rates were observed in both
groups (p=0.45). Age significantly affected patient’s perception for scar cosmesis. Body
mass index (BMI) was incrementally associated with wound disruption.
Conclusion: Tissue adhesive and subcuticular suture for skin closure had similar cosmetic
appearance. Both methods are safe and can be used interchangeably.
Edcyndi M. Tan, MD, Ma. Antoinette P. Mendoza, MD, FPOGS, FPSUOG, FPSMFM
Cebu Doctors’ University Hospital
Introduction: Nowadays, expectant mothers deal with evolving practices, societal expectations,
woes of childcare, and postpartum changes. This could lead to postpartum depression (PPD)
which has been characterized and identified in different countries, however, pre-identification
remains a dilemma. Education, marital violence, and genetic disposition are a few identified
factors.
Objective: The study aimed to predict the occurrence of PPD among patients of a tertiary hospital
in Pasay City from September 2019 to September 2020, using a validated and translated perinatal
risk factors questionnaire and Edinburgh Postnatal Depression Scale (EPDS).
Methodology: This is a cross-sectional prospective study with a minimum sample size of 231
subjects. Primiparous and multiparous subjects delivered by vaginal or cesarean section with live
offspring. Informed consent, instigation of perinatal risk factor questionnaire prenatally and the
EPDS 7 days after delivery were done.
Results: A total of 235 subjects were included in the study. The subjects had a median age of 30
years, majority were single (122, 51.91%), attended college (206, 87.66%) and were employed
(191, 81.28%). Pregnancies were mostly planned (181, 77.02%) and wanted (109, 84.26%);
majority were primigravid (159, 67.66%), primiparous (185, 78.72%), and delivered vaginally
(147, 62.55%). Ten (4.3%) were preterm neonates, and 131 (56%) were males. Prevalence of PPD
was 2.13%. On univariate analysis, high school education, unemployment, unplanned and
unwanted pregnancies were associated with greater odds of PPD among women.
Conclusion: The perinatal risk factor questionnaire correlated with EPDS scores is an effective
instrument to identify who may eventually develop PPD when included during prenatal check-
ups. The researchers believe that the low prevalence among the participants may be due to the
strong family cohesiveness of the Filipinos. Hence, patients identified at risk would be better
monitored and counselled closely after delivery.
Koleen C. Pasamba, MD, Jean Anne B. Toral, MD, MSc, FPOGS, FSGOP
University of the Philippines-Manila, Philippine General Hospital
Introduction: Preterm birth – delivery at less than 37 weeks age of gestation – is one of the
leading causes of neonatal morbidity and mortality in the world. Research and development has
a crucial role in decreasing the rate of preterm birth through discovering means to prevent and
manage the condition.
Objective: The aim of this study was to assess research productivity on preterm birth in
Southeast Asian (SEA) countries and its correlation with socioeconomic characteristics and
burden of disease.
Methodology: A systematic review of preterm birth publications by SEA authors indexed in
Scopus, PubMed, ClinicalTrials.gov and Cochrane was done. Research productivity was assessed
by determining total publications, total citations and total PlumX metrics indices of each SEA
country. The correlation of bibliometric indices, namely Scopus citations, and PlumX metrics
indices (citations, usage, captures, mentions, and social media), with socioeconomic status and
burden of preterm birth in SEA countries were analyzed by computing for the correlation
coefficient (r) and p-value at an alpha of 0.05.
Results: Thailand had the highest number of publications and the highest count across all
bibliometric indices among all countries in SEA. The percent gross domestic product (GDP) per
capita allotted for research and development had direct correlation with publications and
captures while crude birth rates had indirect correlation with publications, citations, and
captures. Neonatal mortality had indirect correlation with publications and captures.
Conclusion: Support for research and development is essential to increase research productivity
in SEA, which in turn may help in finding solutions to decrease the rate of preterm birth in the
region. Further studies are recommended to quantify effect of research productivity on the
decrease of preterm birth rates.
Introduction: Recent advances in the understanding of endometrial cancer have shown that
behavior and prognosis correlate more with molecular profile than histopathologic morphology.
Objective: This study aimed to determine if immunohistochemistry stains for mismatch repair
(MMR) genes are associated with disease outcomes.
Methodology: This is a cross-sectional study using chart reviews conducted among endometrial
cancer patients who underwent surgery as primary treatment (2015-2019).
Immunohistochemistry staining with MMR antibodies – MLH1, MSH2, MSH6 and PMS2 – was
done on formalin-fixed paraffin-embedded tissue blocks to determine MMR status.
Results: A total of 243 patients were included; 230 samples were analyzed for MMR stains.
Demographic data, histology, stage, tumor grade, adjuvant treatment and outcomes did not
correlate with MMR status. There was lymphovascular space invasion in 48% of patients,
irrespective of MMR status. The prevalence of MMR deficiency is 37.39% (95%CI 31.35-43.86).
The odds ratio of disease recurrence or progression among MMRd patients is 1.04 (95% CI 0.49-
2.19).
Conclusion: MMR status did not correlate with clinical profile or surgico-pathologic outcomes.
Although this study was underpowered to determine association between MMR status and risk
of progression owing to the number of patients lost to follow-up, this is the first study to attempt
MMR testing among endometrial cancer patients in the Philippines.
Nina Rojana L. Yu, MD, Regina Rosario M. Panlilio, MD, FPOGS, FPSUOG
University of the Philippines-Manila, Philippine General Hospital
Introduction: In 2008, the International Endometrial Tumor Analysis (IETA) group released a
consensus statement to standardize the sonographic descriptors for key uterine cavity and
endometrial features. While this may minimize the observer subjectivity inherent in sonography,
there are no local studies analyzing its reproducibility.
Objective: To determine reproducibility by estimating interobserver and intraobserver reliability
in describing the vascular characteristics of the endometrium of women with abnormal uterine
bleeding (AUB) using the IETA group terminology.
Methodology: This is a prospective cross-sectional study. Five (5) non-expert (fellows-in-training)
and 5 expert (consultants) raters assessed stored still images of the endometrium obtained from
68 women with AUB and endometrial thickening. Color flow and vascular pattern were evaluated
using the IETA group descriptors. Interobserver agreement was estimated by comparing the
assessments of the non-expert and expert raters, while intraobserver agreement was computed
following repeat assessment after 4 weeks. Interrater agreement of both groups to the reference
assessment was also determined.
Results: Compared to the non-expert raters, the expert raters displayed better interobserver
reliability (κ = 0.74 vs. 0.57) and intraobserver reliability (κ = 0.84 vs. 0.64) in assigning the color
score using IETA’s four-point scoring system. However, both expert and non-expert raters
exhibited markedly worse interobserver reliability (κ = 0.49 vs. 0.34) and intraobserver reliability
(κ = 0.84 vs. 0.63) in assigning the vascular pattern according to IETA’s seven categories. All raters
exhibited moderate to good agreement with the reference assessment for both color score and
vascular pattern.
Conclusion: The reproducibility of assigning color score is good regardless of the degree of
expertise of the rater. However, the reproducibility of describing vascular patterns is significantly
worse for all raters. Both non-expert and expert raters exhibited acceptable agreement with the
reference standard. Expert raters have consistently demonstrated better reliability in their
assessment compared to the non-expert raters.
Introduction: Studies on sexual dysfunctions among gynecologic cancer after treatment are
sparse in the Philippines and data on sexual dysfunction vary greatly within the gynecologic
oncology literature. As the numbers of female cancer survivors continue to grow, there is a
growing need to bridge the gap between the high rate of women's cancer-related sexual
dysfunction and the lack of attention and intervention available to the majority of survivors who
suffer from sexual problems.
OBJECTIVE: To determine the presence of sexual dysfunction among endometrial cancer patients
managed in the institution.
METHODOLOGY: This is a cross-sectional study, which utilized a self-administered, validated
Filipino version of the Female Sexual Function Index (FSFI) questionnaire in assessing the
different domains (desire, arousal, lubrication, orgasm, satisfaction and pain). Descriptive
statistics such as frequency and percentages were used in determining the prevalence of sexual
dysfunction while Kruskal Wallis test and Spearman Rank Correlations were used to determine
the association of sexual dysfunction with age, body mass index (BMI), duration and stage of
endometrial cancer, presence of comorbidities and mode of treatment.
RESULTS: Between May 2020 and January 2021, 53 patients participated in this study. Among
them, 41 (77.36%) have sexual dysfunction. Majority of the respondents either reached up to
high school level (12, 22.6%) or are college graduates (12, 22.6%). Most of them are also self-
employed (21, 51.22%). Twenty-three (56.10%) have children (1-3). Analysis showed no
significant correlation of presence of sexual dysfunction to stage of cancer, BMI, presence of
comorbidities, period of diagnosis and type of treatment received by the patients.
CONCLUSION: The study showed that there was high prevalence of sexual dysfunction among
endometrial cancer patients. Hence, proper screening, diagnosis and counselling should be done
to all patients upon diagnosis to promote better quality of life.
Keywords: endometrial cancer, female sexual function index Filipino version, sexual dysfunction,
quality of life
R-26
Keywords: gestational diabetes mellitus, metformin, insulin, maternal and neonatal outcomes
R-27
Introduction: Cultural and societal expectation on women to accept labor pain and the
physician's focus on vaginal birth progress over pain management translate the idea of pain
management as highly desired by women.
Objective: The study determined the effectiveness of audio and visual distraction methods in
reducing labor pain during the active stage.
Methodology: The randomized controlled trial (RCT) conducted in a government hospital in
Tarlac from the period of June to September 2020 involved the 275 laboring mothers who were
randomized into control (n=91), experimental group 1 (n=98) and experimental group 2 (n=86).
Baseline and post-intervention pain ratings were obtained in the 3 groups using Visual Analogue
Scale (VAS). Dependent t test (before and after pain rating) and one way ANOVA (comparison of
3 groups) were utilized.
Results: The subjects had a mean age of 22.82 years old (SD ±3.72), age of gestation of 38.55
weeks (SD ±1.69), and an initial cervical dilatation of 5.19 cm (SD ±0.54) without any significant
difference according to age (p=0.175), age of gestation (p=0.431), cervical dilatation (p=0.442)
and baseline pain rating (p=0.058) between the 3 groups. There was a statistically significant
increase in pain rating in all 3 groups. Pain rating was statistically significantly higher in the control
group (9.63) when compared to audio (8.45, p=0.000) and visual (8.51, p=0.000). The depiction
of labor curve reveals increasing pain experience with or without non-pharmacologic
intervention. As stress response is the opposite of relaxation, the findings revealed that pain
distraction methods can reduce tension and fear during childbirth.
Conclusion: Access to all available pain relief methods by the mother is critical to effective
management. It highlights these methods, while economical and non-invasive, can be of clinical
application with the goal of promoting positive maternal outcomes respective to manageable
labor pain.
Introduction: The natural form to labor augmentation emanates from the idea concerning the
effect of prostaglandins in evening primrose oil (EPO) that is documented in anecdotal evidence.
Faced with limited evidence largely caused by smaller clinical studies to support its therapeutic
effect, the study materialized to determine its effectiveness on the length of labor.
Objective: The study aimed at determining the effectiveness of intravaginally applied EPO
compared to the commonly used pharmacologic approach using oxytocin on term primigravid
patients undergoing labor augmentation.
Methods: This randomized controlled trial involved 80 mothers (40 control, 40 experimental) in
a government hospital in Tarlac City, Tarlac based on eligibility characteristics (primigravida, term
pregnancy, at least 18-years-old, cephalic fetal presentation, intact amniotic membranes, with
regular prenatal check- up). The control group received the standard oxytocin while the
experimental group had the intravaginal EPO capsules.
Results: The 80 mothers were 21.65 years-old (SD ±4.661) at 39.14 weeks age of gestation (SD
±0.522) with baseline Bishop’s score of 7.04 points (SD ±1.804). Bishop’s scores statistically and
significantly increased with the use of either oxytocin (p=0.000) or EPO (p=0.000). The use of
oxytocin resulted in shorter length of labor (3.37 hours, p=0.000) and higher follow-up Bishop
scores (8.58 points, p=0.001) compared to the EPO capsules (4.55 hours; 7.73 points). EPO’s
effect on Bishop’s scores and labor duration is based on the premise that a cervix that is prepared
for labor augmentation favors progress of vaginal delivery.
Conclusion: The oxytocin treatment for labor augmentation asserts the needed inquiry for EPO
to influence labor length as the former has been proven to have shorter labor duration than the
latter. Worthy of clinical application, the use of EPO still at large, requires conduction of large-
scale research to further strengthen the validity of findings to labor augmentation.
Renee Riza C. Medalla, MD, Jericho Thaddeus P. Luna, MD, FPOGS, FSGOP
University of the Philippines-Manila, Philippine General Hospital
Vanessa Marie T. Lim, MD, FPOGS, Anna Liza C. Salita, MD, FPOGS, FPSUOG,
Ma. Isidora Margarita Yap-Garcia, MD, FPOGS, FPSRM, Christine Joyce M.
Omolida, MD, FPOGS
St. Luke’s Medical Center – Quezon City
Lailanie Jane C. Santiago, MD, Stella Marie L. Jose, MD, MHPEd, FPOGS,
FPIDSOG
University of the Philippines-Manila, Philippine General Hospital
Introduction: Tubo-ovarian abscess (TOA) is common among reproductive-age women but may
also affect the menopausal women. According to Munro, et. al., the prevalence of TOA in pelvic
inflammatory disease (PID) cases is approximately 2.3%. Neutrophil-lymphocyte ratio (NLR) has
been proposed as a significant marker for diagnosis in TOA.
Objective: To determine the level of NLR in predicting medical failure in TOA in a tertiary hospital
in the Philippines.
Methodology: This is a retrospective cross-sectional study, which was done through a chart
review of all cases seen at the obstetric emergency room of a tertiary hospital in the Philippines
from 2014 to 2018. The sample size is 82 participants. Lesions were determined with cut-off
values derived from receiver operating characteristic (ROC) analysis.
Results: Out of the 4,828 gynecologic admissions in the institution, 82 (1.7%) patients were
diagnosed to have TOA. From 2014 to 2018, 82 patients were admitted in a tertiary hospital due
to TOA. A total of 45 (54.9%) patients were managed medically and 37 (45.1%) patients were
managed surgically. The mean age of patients with TOA who underwent medical management
was 30, while for those who had surgical management was 35.65. The transvaginal ultrasound
measurement (mass volume) of the TOA was 141.9 ml for those who underwent medical
intervention and 351.9 ml for those who had surgical management. The NLR mean value was of
5.6 for those who underwent medical management and 13.4 for those who had surgical
management. There was no statistical difference between the medical group and surgical group
in terms of age, gravidity, parity and volume of the TOA. There was a statistical significant
difference between the medical treatment group and the surgical treatment group in terms of
NLR ratio (p=0.037).
Conclusion: This study suggests that NLR can be a simple tool to use to predict the probability of
needing surgical management among patients with TOA.
Introduction: Total laparoscopic hysterectomy (TLH) has been increasingly recommended as the
surgical method for removing the uterus for benign gynecological diseases. Minimally invasive
surgery, with the development of new techniques and instruments, results to faster recovery.
However, its practice in the country has been limited even among gynecologic endoscopists
because of the reported prolonged operating time.
Objective: To determine the rate-limiting steps that prolong operating time in TLH performed by
the most senior fellows-in-training.
Methodology: This is a retrospective, cross-sectional study, using videos and clinical records of
32 patients who satisfied the inclusion criteria between January 2018 and December 2020. TLH
technique used was the 10 steps validated by the European Society for Gynecologic Endoscopy.
Results: The mean total surgical time, total blood loss and uterine size were 226.34 minutes, 150
ml and 7.76 x 7.05 x 4.11 cm, respectively. The longest surgical time of all the steps were observed
in step 6 (colpotomy; 16.02 + 8.02 minutes) and step 8 (vault closure; 24.77 + 11.07 minutes).
There was significant correlation between total amount of blood loss and duration of step 6
(p=<0.001), as well as with step 8 (p=0.010). There was also significant correlation between
uterine size and duration of step 6 (p=0.026), and presence of adhesions and duration of step 6
(p=0.009).
Conclusion: The 2 rate-limiting steps determined to prolong operating time in TLH performed by
the most senior fellows-in-training were colpotomy and vault closure.
Introduction: Cesarean delivery, one of the most common procedures done in the field of
Obstetrics and Gynecology, is the most important risk factor for postpartum infection. Common
postpartum complications associated with cesarean deliveries are endometritis (6-27%), clinically
significant fever (5-24%), and wound infection (2-9%).
Objective: To determine the effects of vaginal preparation before cesarean operation on
postoperative factors and morbidities and to compare the maternal outcomes of patients who
underwent vaginal preparation prior to cesarean section vs. those who had no vaginal
preparation.
Methodology: The study was a prospective randomized controlled trial in which 172 subjects
were randomized to receive vaginal preparation with povidone-iodine solution immediately prior
to cesarean delivery (intervention group) and to no vaginal preparation (control group). The
primary outcome measures were the rate of postpartum endometritis, postoperative fever,
postoperative pain, wound infection, and hematologic factors on postoperative day 1.
Results: The incidence of endometritis was 2.3% in both groups. Febrile morbidity occurred in 4
(4.65%) of the intervention group and 8 (9.30%) of the control group (p=0.231). Wound infection
affected 1.2% of the intervention group and 4.7% of the control group. The incidence of wound
infection was decreased by 8% among patients who were in labor and were given vaginal
preparation (RD -0.08, 95% CI -0.16 to -0.005, p=0.041). There was insufficient evidence to
demonstrate a difference between the 2 groups in terms of endometritis, febrile morbidity and
wound infection in those not in labor.
Conclusion: Vaginal cleansing with povidone-iodine solution immediately prior to cesarean
section may reduce the risk of wound infection after delivery in patients who are in labor. There
was no significant benefit of povidone-iodine vaginal preparation in the risk of postoperative
endometritis, febrile morbidity and postoperative blood loss.
Ashley Ediamy D. Go, MD, Maynila E. Domingo, MD, FPOGS, FPSMFM, FPSUOG
Medical Center Manila
Introduction: Non-Hodgkin’s Lymphoma (NHL) can originate from sites other than the lymph
node, with the uterus being a rare site of involvement. It is difficult to distinguish from primary
neoplasms of the uterus; thus, diagnosis can be delayed leading to poor prognosis. Treatment
poses another difficulty because of the absence of standard treatment. Individualization of
treatment is recommended.
Course of the Patient: This is a case of a 17-year-old nulligravid admitted because of vaginal
bleeding and difficulty in urination. She had a 5-month history of intermittent, profuse vaginal
bleeding. On examination, there was a 10 x 10 cm firm, irregular, friable mass protruding out of
the cervical os and extending to the lower third of the vagina. Biopsy revealed malignant round
cell neoplasm, considering poorly differentiated carcinoma, High-grade Sarcoma, Lymphoma.
Immunohistochemistry favored High-Grade Lymphoma. She had episodes of seizure,
electroencephalogram (EEG) was normal and cranial computed tomography (CT) scan showed
brain metastasis. She underwent 2 cycles of chemotherapy with Methotrexate,
Cyclophosphamide, Vincristine. She expired due to acute respiratory and renal failure,
obstructive uropathy secondary to Non-Hodgkin’s Lymphoma of the uterus with central nervous
system metastasis.
Discussion: NHL is the most common type of lymphoma, with 1/3 affecting the extranodal
regions. Involvement of the female genital tract is rare, seen in approximately 2%. The incidence
of NHL of the uterine corpus ranges from 0.54 to 0.64%. Clinical presentations are abnormal
uterine bleeding, abdominal pain, pelvic pain associated with palpable mass and urinary
symptoms. Biopsy is the most common and most useful method for its diagnosis.
Immunohistochemistry studies are important to determine the type and subtype of lymphoma.
There is no evidence-based recommendation and no formal protocol for the management of
uterine lymphoma due to inadequate number of cases. The treatment of patients needs to be
individualized with surgery, chemotherapy, irradiation, or a combination of these. However, the
prognosis usually remains poor with five-year survival reported by recent study on lymphoma.
Introduction: Menstrual cup-associated toxic shock syndrome is a severe, fatal, super antigen
toxin-mediated illness which leads to multiple organ-system failure early in its course. Pathology
of the disease is centered on the TSS 1 toxin produced by Staphylococcus aureus accumulated in
the menstrual blood within the cup. To the best of our knowledge, at present time there are only
3 international journals under the specialty of Internal Medicine who have published case reports
of menstrual cup-associated toxic shock syndrome. In the local setting, there is rare, if not limited,
knowledge in terms of incidence, morbidity and mortality rates of this disease and our index
patient may be the first Philippine reported case.
Course of the Patient: Reported is a 30-year-old healthy Filipina, a known menstrual cup user
for 6 years, who reported prolonged use of menstrual cup of more than 12 hours on day 3 of
menses. Her diagnosis was confirmed by the Case Definition Criteria set by the Center for Disease
Control (CDC) 2011, where she fulfilled 5 of the clinical criteria: fever, rash, desquamation and
hypotension, with the presence of multisystem involvement – vomiting, myalgia, vaginal and
oropharyngeal hyperemia. This was further supported by the heavy growth of methicillin-
resistant Staphylococcus aureus in her vaginal discharge culture. She was treated empirically
with antibiotics that lead to successful treatment outcomes with no recurrence.
Discussion: At this day and age, we give women freedom to choose what is right and appropriate
for them, including choice of menstrual hygiene products. It is a personal decision often
influenced by cultural acceptability, user preferences and affordable options. This paper is
written to promote knowledge, advocate wellness and most of all to educate clinicians to have
high index of suspicion on this disease and eventually prevent its catastrophic sequalae.
Keywords: toxic shock syndrome, menstrual cup, methicillin resistant, TSS1 toxin Staphylococcus
aureus
IC-6
Introduction: Abdominal pregnancy is a rare form of ectopic pregnancy that accounts for 1-1.4%
of all pregnancies. It refers to a pregnancy that has implanted in the peritoneal cavity, external
to the uterine cavity and fallopian tubes. Most are terminated early due to poor fetal prognosis
or high likelihood of maternal hemorrhage. It poses a great risk to both maternal and fetal
survival and has high chances of morbidity or mortality. Those that reach advanced gestation and
even term with viable fetal outcome are indeed more special and unique. Misdiagnosis is
common because symptoms are usually non-specific.
Course of the Patient: This is a term abdominal pregnancy in a 40-year-old G5P4 (4004) who
underwent emergency cesarean section for a preoperative diagnosis of placenta previa and
malpresentation. She had poor prenatal check-ups and her two ultrasound scans revealed
intrauterine pregnancy. Intraoperatively, a live, abdominal pregnancy was diagnosed, with good
fetal outcome. The placenta was noted to be markedly adherent to the posterior wall of the
uterus invading up to the myometrial tissue, the right fallopian tube and right ovary inferiorly
and the intestinal serosa superiorly, hence, total abdominal hysterectomy with right salpingo-
oophorectomy was also done. The rest of the hospital days were uneventful. She was then
discharged on the 6th hospital day with no other complications.
Discussion: The goal of management for this case was to deliver the baby safely with careful
assessment of the placenta as not to induce hemorrhage and prevent life-threatening condition
which may cause maternal morbidity or mortality.
Introduction: Co-existence of systemic lupus erythematosus (SLE) and COVID-19 has paved way
to a constellation of articles aiming to find clues on potential peculiarities of COVID-19
epidemiology and course among those with SLE. This co-existence is rare but more so if
associated with pregnancy that can lead to significant mortality and morbidity to both mother
and baby. Appropriate management presents major dilemma and requires multidisciplinary
approach.
Course of the Patient: A 37-year-old G4P2 (2012), 23 weeks age of gestation, with no co-
morbidities, and with 2 unremarkable previous pregnancies, presented with unstable vital signs,
generalized pallor, pale conjunctiva, oral ulcers, crackles on auscultations, tea-colored urine and
anasarca. Work-up revealed severe anemia, elevated BUN, creatinine and urine
protein:creatinine ratio, hematuria with cast, positive Coomb’s test, bilateral pneumonia on
chest x-ray, low albumin and abnormal 2D-echo findings. She was eventually diagnosed with SLE
based on lupus titer. COVID-19 RT-PCR turned out to be positive. She underwent dialysis, blood
transfusions and medical management; however, due to multiple complications, the patient
expired.
Discussion: Lupus nephritis and pulmonary manifestations of SLE in pregnancy can increase the
maternal and fetal morbidity and mortality. Although successful pregnancy outcomes are
possible for SLE patients, miscarriages, preterm deliveries, and intrauterine fetal demise remain
a concern, requiring close monitoring and intensive multi-specialty team approach. This case
highlights a difficult clinical scenario having a possible flare-up of lupus pneumonitis during the
COVID-19 outbreak. Presenting symptoms between these two diseases comprise significant
overlap including pulmonary manifestations. This caused difficulty in early diagnosis and
management. Likewise, because of the risk and low chances of survival of the fetus due to
extreme prematurity, the decision was to delay the delivery until viability. All pregnancies with
SLE should be planned during periods of disease quiescence prior to conception. Hence, active
SLE at the time of conception is a strong predictor of adverse maternal and obstetrical outcomes.
Introduction: One of the rare types of ectopic pregnancy leading to maternal and neonatal
morbidity and mortality is broad ligament pregnancy. In literature, its incidence is reported as 1
in 613 ectopic pregnancies and 1 in 183,900 pregnancies. In our institution, there are no other
cases of broad ligament pregnancy in the last 5 years. Beyond its rarity, broad ligament
pregnancies poses a diagnostic challenge, as it is elusive on imaging and it masks behind the
manifestations of the more common types of ectopic pregnancies.
Course of the Patient: This is a case of a 32-year-old multigravid who was 16 5/7 weeks gestation
and who presented to the emergency room with severe abdominal pain, hypotension,
tachycardia and tachypnea. She underwent emergency exploratory laparotomy for a suspected
ruptured ectopic pregnancy and intraoperatively, a large complex mass with a 3-cm point of
rupture was seen adherent to the left ovary, thus a left salpingo-oophorectomy was done for a
suspected ovarian pregnancy. Postoperatively, the patient had several episodes of seizure
activity and eventually expired secondary to complications of the intractable hypovolemic shock.
Histopathology later confirmed the diagnosis of broad ligament pregnancy.
Discussion: The clinical manifestations of broad ligament pregnancy are similar to other ectopic
pregnancies, with minimal or no signs and symptoms in early gestation to massive intra-
abdominal bleeding and shock as the pregnancy progresses and ruptures. Such was the case of
this patient who was early in her second trimester. Broad ligament pregnancies are commonly
misdiagnosed as tubal pregnancies on routine ultrasound, and correct diagnosis is usually made
intraoperatively through the location of the pregnancy within its anatomical borders; lateral to
the uterus, medial to the pelvic side walls, superior to the pelvic floor, and inferior to the fallopian
tube. Mainstay treatment is surgical intervention, as with this patient who came in with signs of
shock.
Leobert Julienne A. dela Peña, MD, Ronald Lanz R. Latap, MD, FPOGS, FSGOP
West Visayas State University Medical Center
Introduction: Synovial sarcoma, also called malignant synovioma, can arise from different types
of soft tissues such as muscles and ligaments in the arms, legs, foot, near the joints and rarely in
the abdomen. It is further classified into biphasic, monophasic or poorly differentiated.
Course of the Patient: This is a case of a 19-year-old nulligravid presenting with hypogastric pain
and right lower quadrant mass. Computed tomography (CT) scan revealed complex ill-defined
mass with blood clots and moderate ascites. Baseline tumor markers were within normal. She
underwent exploratory laparotomy, peritoneal fluid cytology, right salpingo-oophorectomy with
tumor debulking with findings of a pelvic mass attached to the right ovary, fallopian tube,
posterior broad ligament and uterus. Histopathologic result revealed malignant spindle cell
neoplasm. Immunohistochemical studies showed positive CD 99, TLE 1, Bcl-2, S100 and Desmin
confirming monophasic synovial sarcoma. Following the American Joint Committee on Cancer
(AJCC) staging system, the final stage of the patient was 1A (T1 N0, M0, GX) and was for adjuvant
Ifosfamide-based chemotherapy.
Discussion: Synovial sarcoma is a rare type of soft tissue neoplasm that affects adolescents and
young adults aged 15-40 years old. It originates from primitive or uncommitted mesenchymal
cells that eventually differentiate to resemble synovial cells. It is caused by unique chromosomal
translocations of t(X;18) (p11.2;q11.2) found in more than 90% of cases resulting in formation
two fusion genes: SYT-SSX1 or SYT-SSX2. Magnetic resonance imaging (MRI) is the modality of
choice. Immunohistochemistry has been proven to be pivotal in its diagnosis mainly of the
monophasic variant, primarily demonstrating positive TLE1, CD99, Bcl-2, S-100 and Desmin while
negative for CD34. Adequacy of initial surgery is an important prognostic factor, with a 5-year
survival rate of 76% following a complete cytoreductive surgery. Adjuvant chemotherapy with
Ifosfamide with or without Doxorubicin may be given but there are no specific guidelines because
of its rarity. The knowledge of its occurrence in unusual locations is necessary to avoid its
misdiagnosis which may lead to delay in treatment and tumor metastasis leading to poorer
prognosis.
Introduction: Gestational trophoblastic neoplasia (GTN) is the collective term for invasive mole,
choriocarcinoma, placental site trophoblastic tumor (PSTT), and epithelioid stromal tumor (EST).
Chemotherapy remains to be the cornerstone of management. However, adjuvant treatment
may include surgery, radiation and vaginal artery embolization.
Course of the Patient: This is a case of a 32-year-old G2P1 (1011), who was managed as GTN
III:14 and underwent total abdominal hysterectomy (TAH). She developed vesico-uterine fistula
and was advised for computed tomography (CT) scan with intravenous pyelogram (IVP);
however, the patient was lost to follow-up. Two days prior to admission, the patient had vaginal
bleeding soaking 3 diapers per day, which prompted consultation and subsequent admission. A
multidisciplinary approach with gynecology trophoblastic section, urology and interventional
radiology department was done. The plans were to control the bleeding, work up the vesico-
uterine fistula, and give salvage chemotherapy. She underwent pelvic angiogram then
cervicovaginal artery embolization which significantly controlled the bleeding. She received 2
regimens of salvage chemotherapy with etoposide and cisplatin with etoposide, methotrexate
and dactinomycin (EP-EMA) for 5 cycles followed by carboplatin-paclitaxel for 3 cycles. With still
persistent high levels of ß subunit of human chorionic gonadotropin (ß-hCG), the patient decided
to discontinue treatment and opted for terminal discharge.
Discussion: Choriocarcinoma is a rapidly growing tumor which invades both myometrium and
blood vessels to create hemorrhage and necrosis. The bleeding can be caused by malignant
tumor extension, infection, surgery and pelvic radiation due to changes in pelvic vascular
anatomy. The angiographic approach to control the bleeding is minimally invasive and safe.
Arterial embolization is 69-100% effective and the bleeding is controlled up to 95.7% in 24 hours.
The procedure decreases the need for blood transfusion and the incidence of new bleeding
episodes as well as improves the general condition of the patient.
Marth Louie Z. Tarroza, MD, DPOGS, Sybil Lizanne R. Bravo, MD, MSc, FPOGS,
FPIDSOG
University of the Philippines-Manila, Philippine General Hospital
Introduction: The effect of COVID-19 on patients with human immunodeficiency virus (HIV) has not been
well-studied extensively. This case series presents symptoms, clinical course, and outcome in this special
population. Knowing the effects of COVID-19 disease in this vulnerable population can help us obtain good
clinical outcomes and prevent possible maternal morbidity and mortality.
Course of the Patients: First case is a 27-year-old G4P2 (2012), 38 4/7 weeks age of gestation (AOG), HIV-
positive, COVID-19 asymptomatic, who came in due to labor pains and underwent low segment cesarean
section (LSCS) with bilateral tubal ligation (BTL). She has been a known HIV patient since December 2018
and has been on anti-retroviral therapy (ART) since January 2019. She tested positive for COVID-19 RT-
PCR prior to admission. Second case is a 28-year-old G2P1 (1001), 37 weeks AOG, with 1 previous cesarean
section, HIV-positive, COVID-19 asymptomatic, who underwent repeat LSCS. She has been a known case
of HIV since 2019 and is on ART. She also tested positive for COVID-19 RT-PCR prior to admission. Third
case is a 22-year-old G3P2 (1102), 37 1/7 weeks AOG by ultrasound, with 1 previous cesarean section (CS),
HIV-positive, to consider COVID-19 recovered, who came in due to watery vaginal discharge and
underwent repeat low segment CS. She has been a known case of HIV since 2019 and is on ART. She had
cough, colds and ageusia at 26 weeks AOG but no SARS COV-2 RT-PCR swab was done. Home quarantine
was completed for 14 days. Her COVID-19 RT-PCR on admission was negative, but her COVID-19 total
antibody assay was reactive. Last case is a 22-year-old G2P1 (1001), 37 5/7 weeks AOG, with 1 previous
CS, HIV-positive, COVID-19 asymptomatic, who came in due to labor pains and underwent repeat LSCS.
She has been a known case of HIV since 2018 and was initially on ART, which she took only for 3 months.
She was lost to follow up until 1 month prior to admission. She was referred back to an HIV Hub for
reinstitution of ART. She also tested positive for COVID-19 RT-PCR prior to admission. All of their CD4
count levels were within acceptable levels (316-950 cells/uL) and majority of them were virally
suppressed. All of them had good clinical outcomes.
Discussion: Contradicting theories were observed in studies on COVID-19 and persons living with HIV
(PLWH). Some suggested that HIV infection can increase the risk of having a poorer course of COVID-19
because of the abnormal immune response but some, due to the mild immunosuppression and the
possible protection from ART, believed that HIV patients may show a milder COVID-19 disease
presentation. Based on the clinical course of the 4 cases, which was also supported by several studies, it
showed that the clinical presentation, levels of inflammatory markers and course of COVID-19 disease
were similar for the general population and in PLWH. Current evidence also showed that the risk of disease
severity is dependent on the chronic medical conditions commonly present in PLWH like cardiovascular
diseases, chronic lung disease and diabetes mellitus. The index cases can somehow possibly benefit from
the lymphopenia caused by HIV infection and immunomodulatory effects of Tenofovir, but these
assumptions need to be supported by more research and more randomized clinical trials.
Ana Patricia C. Vargas, RCh, MD, MBA, Viktoria Ines P. Matibag, MD,
Maria Anna Luisa F. Dalawangbayan, MD, FPOGS, FPSUOG
University of the Philippines-Manila, Philippine General Hospital
Introduction: Abdominal pregnancy is a rare type of ectopic pregnancy with incidence of 1 out
of 10,000 pregnancies. This type generally does not reach term due to high incidence of morbidity
and congenital anomalies. Maternal hemorrhage due to placental detachment is a common
cause of mortality, hence, leaving it in-situ is considered a safer option. This case highlights the
importance of anticipation and preparedness to different scenarios that may arise
intraoperatively. To the best of our knowledge, this is the first case of advanced abdominal
pregnancy reported with successful delivery of a term baby with complete placental extraction.
Course of the Patient: This is a case of a 29-year-old G2P2 (1001), on her 38th week of gestation,
who consulted due to generalized abdominal pain. Ultrasound findings revealed an empty uterus
with a live term fetus occupying the abdominal cavity. Magnetic resonance imaging (MRI)
described the placenta’s possible attachment to the abdominal aorta. A multidisciplinary
subspecialty team carried out the preoperative preparations. Patient underwent exploratory
laparotomy, fetal extraction to a live baby with no gross anomalies. Placenta was not
manipulated. However, spontaneous detachment was noted after cord clamping which resulted
to bleeding. Placental extraction was carried out successfully with activation of massive blood
transfusion protocol. The post-operative course was uneventful both for the mother and the
baby.
Discussion: Abdominal pregnancy is a rare form of ectopic pregnancy where implantation takes
place in the peritoneal cavity. Its management lies not solely in the delivery of a live baby but
more importantly in the approach on placental management since hemorrhage is the common
cause of maternal mortality. The multidisciplinary team approach and adequate preoperative
preparation in the index case had a great positive impact on the intraoperative call to do placental
extraction which fortunately, was carried out successfully. The management of abdominal
pregnancy is, therefore, individualized.
Introduction: The diagnosis of a brain tumor is a life-changing and stressful event. This is
heightened if the patient is an expectant mother. Intracranial neoplasms typically present with
nonspecific symptoms of cerebral dysfunction, those of which are easily confounded in
pregnancy since several conditions that mimic an increased intracranial pressure may be
attributed to normal physiological changes.
Course of the Patient: This is a case of a 34-year-old G2P1 (1001), with a history of recurrent
bitemporal headaches, nausea and vomiting, and an isolated episode of loss of consciousness.
At 35 4/7 weeks age of gestation (AOG), the patient was eventually diagnosed with an intracranial
neoplasm, accompanied by extensive perilesional edema and leftward subfalcine herniation, via
magnetic resonance imaging (MRI). An elective cesarean section followed by right frontal
craniotomy and excision of tumor was done at 37 weeks age of gestation. Post-operative course
was unremarkable. Surgical histopathology revealed an olfactory nerve schwannoma.
Discussion: Schwannomas of the anterior cranial fossa are extremely rare. Fewer than 70 cases
of olfactory nerve schwannoma have been reported worldwide since 2018. The expected
hypervolemic state of normal pregnancy by intravascular volume expansion and water retention
can potentially exacerbate an already increased intracranial pressure. Uncontrolled cerebral
edema secondary to a brain tumor may precipitate such changes, with danger of acute herniation
syndromes that can cause permanent neurological dysfunction and potentially fatal herniation.
Moreover, subfalcine herniation, as in the patient’s case, poses a risk of cingulate gyrus
herniation leading to compression of the distal anterior cerebral arteries, and can result in
ischemia or infarction. This case report highlights the challenges faced by obstetricians and
neurosurgeons towards balancing maternal and fetal welfare in terms of detection, diagnosis,
medical management, timing and method of delivery, and surgical intervention, when presented
with a symptomatic intracranial neoplasm in pregnancy.
Introduction: Endometrial stromal sarcomas (ESS) arising from the cervix is uncommon. The
occurrence of a high-grade malignancy in a very young premenopausal patient poses the
dilemma on optimal surgical approach and multimodality adjuvant treatment in the absence of
clear management guidelines.
Course of the Patient: C.P., a 17-year-old nulligravid, consulted for heavy vaginal bleeding. She
underwent vaginoscopy revealing a mass occupying the vaginal canal. On internal examination,
the cervical mass was occupying the vaginal canal with no forniceal involvement. Biopsy and
immunohistochemistry studies of the mass were performed with findings suggestive of low-
grade stromal sarcoma. The patient underwent extrafascial hysterectomy with bilateral salpingo-
oophorectomy (EHBSO) with lymphadenectomy. The anterior lip of the cervix was converted to
a 10 x 6.0 x 5.0 cm friable, necrotic mass. The posterior lip of the cervix, uterus, bilateral adnexa
and the rest of the abdominal organs were grossly normal. The histopathologic diagnosis was
high-grade ESS confined to the uterine cervix, positive for lymphovascular space invasion. The
patient received 4 cycles of systemic chemotherapy with Ifosfamide-Doxorubicin to be followed
by vaginal brachytherapy. Medroxyprogesterone acetate was started.
Discussion: Extrauterine ESS is rare and its natural history, prognostic factors, and optimal
treatment is limited due to its rarity. Complete surgery for ESS is total hysterectomy with bilateral
salpingo-oophorectomy (THBSO) in stage I patients and removal of enlarged lymph nodes and
debulking of extrauterine disease is done in stages II-IV. Most recommendations for adjuvant
treatment with chemotherapy, radiotherapy, and hormonal therapy have been based on
extrapolation from treatment used for similar stage uterine ESS. Prognosis depends on the stage
of tumor, grade, surgical margins, age, optimal surgery, number of mitoses, and vascular and
lymphatic invasion. Genetic testing may also play a role in the prediction of prognosis.
Introduction: Cesarean scar pregnancy is a rare form of ectopic pregnancy. The incidence
approximates 1 in 2000 normal pregnancies and has increased with the cesarean delivery rate.
Transvaginal ultrasound has major role in establishing the diagnosis.
Course of the Patient: This was a case of an asymptomatic patient with a cesarean scar pregnancy.
Serial transvaginal sonology was done starting at 6 weeks age of gestation (age of gestation). The
last ultrasound result was at 9 weeks AOG with the following sonologic description: The
gestational sac was located at the lower anterior isthmic portion, the chorionic implantation
extended to the whole thickness of the isthmic wall on the left just above the internal os. The
urinary bladder was intact. Abundant color flow was noted surrounding the implantation of the
early placenta. No myometrium was seen between the sac and bladder. Sonologic diagnosis was
exogenic-type of cesarean scar pregnancy and possible placenta accreta. Quantitative β subunit
of human chorionic gonadotrophin (β-hCG) revealed >10,000 mIU/mL. She was managed
surgically with an open laparotomy with excision of cesarean scar pregnancy, curettage of the
remaining products of conception and repair of the scar. The left uterine artery was also ligated
due to profuse bleeding during uterine repair. The surgery was successful and post-operative
course was unremarkable.
Discussion: In the management of an asymptomatic, exogenic-type of cesarean scar pregnancy,
timely diagnosis and prompt treatment are essential to avoid life-threatening complications such
as hemorrhage and uterine rupture. Transvaginal ultrasound with Doppler is the gold standard
for the diagnosisbut magnetic resonance imaging (MRI) may be used if transvaginal ultrasound
result was equivocal. There is no established management for cesarean scar pregnancy.
Treatment should be tailored according to gestational age, β-hCG levels, type of cesarean scar,
experience and availability of facilities. With early diagnosis and treatment, fertility preservation
may be achieved.
Introduction: Germ cell tumor is the most prevalent ovarian tumor in young women between 10
to 30 years of age. However, immature teratomas account for only 20% of the malignant ovarian
tumors found in adolescent age group. More uncommon is the occurrence of immature teratoma
causing Anti-N-methyl-D- aspartate (Anti-NMDA) receptor encephalitis-like and Guillain-Barré
Syndrome (GBS).
Course of the Patient: This is a case of 15-year-old nulligravid, who initially presented sudden
behavioral change and symmetrical weakness of both lower and upper extremities with
concomitant seizure episodes and with palpable lower abdominal mass. The patient was
diagnosed to have GBS and treated with intravenous immunoglobulin causing resolution of
neurologic symptoms months after. During the management of GBS, the patient noted increasing
abdominal girth. Tumor markers showed elevated AFP, CA 125 and LDH. Imaging study revealed
a predominantly solid ovarian mass, hence, malignancy was considered. Once the medical
condition stabilized, the patient underwent fertility sparing surgery with final histopathologic
result of immature teratoma.
Discussion: Paraneoplastic syndrome is a rare neurological disorder caused by abnormal immune
system reaction that develops from the remote effects of tumor cells. The ovarian teratoma has
neural tissue which acts as antigenic material. The newly formed onco-neural antibodies circulate
in the serum or CSF where it is then able to bind to the NMDA receptor that is primarily expressed
in the hippocampus and forebrain neurons. Anti-NMDAR encephalitis is an autoimmune disorder
with a typical sequential presentation: acute onset of prodromal symptoms, followed by a
psychiatric manifestation, then decreased level of consciousness and seizures, and lastly,
autonomic disability. GBS was considered due to the classic progressive ascending motor
weakness and eventual areflexia. This is due to the immune reactions directed against epitopes
in Schwann cells which can cause the acute demyelinating form of GBS. However, screening for
well-characterized paraneoplastic antibodies against intracellular antigens must be done to
further support the diagnosis.
Rochelle Mae M. Supan, RN, MD, Junette Grace A. Ko, MD, FPOGS, FPSGE
Davao Regional Medical Center
Introduction: Herlyn Werner Wunderlich Syndrome (HWWS) is a rare form of mullerian duct
anomaly characterized by a combination of uterine didelphys, obstructed hemivagina, and
ipsilateral renal agenesis. Internationally, its incidence is 0.1-3.8% and among the reported cases,
none presented with a concomitant adrenal gland agenesis. This is the first case report of a
diagnosed HWWS with a concomitant unilateral adrenal gland agenesis.
Course of the Patient: This is a case of a 10-year-old Filipino who presented with severe cyclic
abdominal pain. Magnetic resonance imaging (MRI) results showed two separate uteri and
cervices, obstructed left hemivagina, and absent left kidney and adrenal gland. This patient has
no symptoms of adrenal insufficiency, and serum cortisol and adrenocorticotropic hormone
(ACTH) levels were within normal limits. She underwent vaginoscopy and resection of the
longitudinal vaginal septum. Postoperatively, the regular menstrual cycle continued and was no
longer associated with dysmenorrhea. Follow-up after six months revealed no recurrence of
hematocolpos on 3D transrectal sonography.
Discussion: A high index of suspicion is the key to diagnose Herlyn Werner Wunderlich syndrome,
especially in patients who present with cyclic pelvic pain during puberty and those who have
findings of renal anomaly. The preferred surgical approach for these patients is resection of the
vaginal septum since the main reason for the symptoms is the physical obstruction of the
menstrual flow. This procedure is associated with a successful future reproductive performance,
if timely done. The incidental finding of concomitant unilateral adrenal gland agenesis, which in
itself is also a rare occurrence, in a diagnosed HWWS brings the possibility that other abnormality
or defects may be associated with this syndrome and not just what is presently known. The
congenital anomaly involving the reproductive organ poses a challenge in the patient’s capacity
to bring about a successful pregnancy. Adding to that is the possibility of developing adrenal
insufficiency during stressful situations or during pregnancy.
Princess Bianca DL. Palabrica, MD, Maria Therese B. Mallen, MD, FPOGS,
FIFEPAG, Germaine Aldrene C. Tan, MD
University of Santo Tomas Hospital
Introduction: Isolated fallopian tube torsion is an infrequent but significant gynecological cause
of pelvic pain in female patients, with literature approximating its overall incidence as 1 in 1.5
million women, and incidence of which in pediatric and adolescents is difficult to determine.
Locally, there has never been a published paper regarding the condition in young adolescents,
emphasizing its rarity.
Course of the Patient: A 12-year-old female presented with right lower quadrant (RLQ) pain. She
was initially treated for urinary tract infection and a whole abdominal ultrasound done prior to
referral to the institution showed a cystic structure in the mid-pelvic region and an inflamed
appendix. The abdomen was soft with direct and rebound tenderness at the RLQ and hypogastric
area. On rectal examination, pelvic organs could not be fully evaluated due to voluntary guarding.
Abdominal CT scan revealed a 10.0 x 8.4 x 7.4 cm thick-walled cystic pelvic mass, probably
ovarian, and a normal appendix measuring 0.6 cm. Assessment was adnexal pathology, probably
ovarian. Pelvic laparotomy was performed and upon exploration, there was a hemorrhagic
pelvoabdominal mass which measured 13.0 x 11.0 x 8.0 cm, found to be a cystically enlarged
right fallopian tube, twisted once on its vascular pedicle. Upon untwisting, the fimbriated end
was noted to be necrotic. The left tube, left ovary and the uterus looked normal. Right
salpingectomy was performed.
Discussion: The entity is difficult to recognize pre-operatively because of its vague clinical
presentation. Abdominal tenderness may present with or without peritoneal signs. There may be
adnexal tenderness, but a mass is not always palpable. There is no specific laboratory finding and
radiologic diagnosis is also limited. Isolated tubal torsion should be considered in cases of acute
lower abdominal pain since awareness and early detection of the condition, especially in children
and adolescents, allows early surgical intervention that may prevent removal of the tubes and
render preservation of fertility.
Sherlyn Marie O. Ingco, MD, Armi Angela C. Lara-Roy, MD, PTRP, FPOGS,
FPSMFM
Southern Philippines Medical Center
Introduction: Aortic dissection (AoD) is an extremely rare condition during pregnancy. Because
of the heightened risk for significant morbidity and high rates of mortality for the mother and the
fetus, it remains an important cause for concern during pregnancy.
Course of the Patient: This is a case of a 36-year-old G2P1 (1001), 32 weeks pregnant who
presented with back pain and exertional dyspnea was initially managed as COVID-19 suspect with
bibasal pneumonia. Work-up revealed that the patient was negative for COVID-19 and antibiotic
coverage didn’t provide relief hence 2D echo was done revealing aortic dissection Stanford type
A, De Bakey I, confirmed by computed tomography (CT) angiogram. The patient was managed
medically while waiting for the surgical plan; however, her labor progressed. She underwent
primary cesarean section with bilateral tubal ligation under continuous epidural blockade. She
was discharged with heart failure medications while waiting for her surgery which is the Modified
Bentall’s procedure.
Discussion: AoD is a serious and life-threatening condition in which the inner layer of the aorta
develops a tear creating a false channel. Diagnosis is done by imaging with CT angiography. AoD
in pregnancy is a rare condition commonly diagnosed during the third trimester and early
postpartum period. Pregnancy alone is considered an independent major risk factor. AoD may
be labelled as type A (ascending aorta involved) or type B (ascending aorta not involved) based
on the Stanford classification and type I (involves ascending and descending aorta), type II
(involves ascending aorta only), or type III (involves descending aorta only, commencing after the
origin of the left subclavian artery) based on the DeBakey classification. Type A (DeBakey I & II)
carry a high mortality rate if left untreated hence, surgical intervention is warranted. For our case,
she is to undergo Modified Bentall procedure at a later schedule.
Introduction: Gestational trophoblastic neoplasia (GTN) is the malignant end of the gestational
trophoblastic spectrum which arises from abnormal proliferation of placental trophoblasts.
These tumors arise from any form of pregnancy and are characterized clinically by their
aggressive invasion into the endometrium and myometrium and propensity to widely
metastasize. Common clinical presentation is vaginal bleeding related to the invasive tumor
eroding the uterine vessels and uterine enlargement. It is relatively uncommon for GTN to
present with symptoms related to metastasis without a primary uterine lesion.
Course of the Patient: A 25-year-old G2P1 (1011), presented with a 2-month history of dyspnea
and easy fatigability. She was initially managed as a case of pulmonary mass, malignant vs.
metastatic, rule out pulmonary tuberculosis. Further evaluation revealed an intermittent vaginal
bleeding and a positive pregnancy test result. Her obstetric history was significant for one term
delivery and one spontaneous abortion. Quantitative serum β subunit of human chorionic
gonadotrophin (β-hCG) was elevated at 258,400 mIU/ml. Transvaginal ultrasound scan revealed
normal-sized uterus with thin endometrium and normal Doppler studies. No uterine or adnexal
mass was noted. Based on the clinical history of spontaneous abortion in the past, intermittent
vaginal bleeding, and symptoms of exertional dyspnea and easy fatigability, associated with
elevated serum β-hCG levels and metastatic lesions, a clinical diagnosis of GTN IV:17 was
established.
Discussion: This highlights a rare clinical presentation of GTN as the patient mainly presented
with symptoms related to a metastatic disease to multiple organs with minimal gynecologic
symptoms and no primary uterine lesion. This also demonstrates how the medical team was able
to think outside the box and work collaboratively to correctly diagnose the case as well as to
properly manage the patient.
Ma. Rosila Flor DJ. Escudero, MD, MBA, Lyra Ruth C. Chua, MD, FPOGS,
FPSUOG, FPSRM
The Medical City
Introduction: Polypoid adenomyoma is a rare benign endometrial tumor among teenagers. The
management of polypoid adenomyoma in a teenage patient is a great challenge to gynecologists
which include combination of medical and surgical techniques to assure safety and success in
order to preserve reproductive functions.
Course of the Patient: This is a case of an 18-year-old nulligravid who came in with a chief
complaint of a bulging introital mass. Since menarche, she had irregular cycles occurring every
1-3 months, moderately to heavy menstrual bleeding using 2 baby diapers lasting 1-2 weeks. Five
days prior to admission, she noticed a sudden presence of a fleshy mass about 4 cm in diameter,
described as non-tender, protruding from her vagina. Four days prior to admission, the mass
which measured 7 x 9 cm and which was associated with foul smelling vaginal discharge, minimal
bleeding, hypogastric pain and lower back pain, prolapsed out of her vagina. Biopsy was done,
and histopathology showed adenomyoma. GnRH agonist was administered, and after a month,
the mass was noted to have decreased in size, fallen off and was no longer visible in the introitus.
Saline infusion sonohysterography (SIS) and hysteroscopic resection were done with
intraoperative findings of an attachment of the pedicle on the posterior fundal area with diffused
thickening endometrial lining. Histopathology showed pedicle of adenomyoma consistent with
endometrial polyp. Months after the procedure, the patient reported to have regular monthly
menstrual cycle with no other symptoms.
Discussion: Polypoid adenomyoma is a rare benign endometrial tumor of mixed epithelial and
mesenchymal origin. It may mimic several disease conditions on imaging and clinical
presentation and may be quite confusing hence several possible differential diagnosis were
considered for this case including prolapsed submucous myoma, non-puerperal uterine inversion
and gestational trophoblastic tumors. This case report shows the rarity of polypoid adenomyoma
in a young nulligravid. The clinical presentation varies among age groups, hence, management is
always individualized. A step-by-step process, from obtaining complete history, physical
examination, imaging and diagnostic procedures, aids in choosing the appropriate medical and
surgical management.
Introduction: Mature cystic teratoma of the ovary, or dermoid cyst, is the most common type of
ovarian teratoma and the most common type of ovarian germ cell neoplasm. However, its
malignant transformation is an uncommon complication and occurs only in approximately 2% of
cases. In the Philippines, there has been only two reported cases of this tumor.
Course of the Patients: Presented are two cases: the first case is in a 31-year-old G2P2 (1102)
who presented with right lower quadrant abdominal pain and the second case in a 41-year-old
G2P2 (2002) who also presented with right lower quadrant pain but with an associated mass on
palpation. The first case underwent exploratory laparotomy, right salpingo-oophorectomy with
frozen section, which revealed a squamous cell carcinoma arising from a cystic teratomatous
germ cell tumor, and subsequent left oophorocystectomy, peritoneal fluid cytology, and
omentectomy. The final stage was IA. However, 2 months later, the patient had tumor recurrence
and underwent total abdominal hysterectomy, left salpingo-oophorectomy, en bloc resection
and anastomosis of ileum and sigmoid with partial cystectomy. The second case underwent total
abdominal hysterectomy, bilateral salpingo-oophorectomy, peritoneal fluid cytology and cell
block, bilateral lymph node dissection and total omentectomy. The final stage was stage IIIC. Both
had final histopathology of squamous cell carcinoma arising in a mature cystic teratoma. Both
women were advised chemotherapy but only case 1 was able to comply. Unfortunately, both
died within a year.
Discussion: Malignant transformations arising from a cystic teratoma are exceedingly rare with
no guidelines on management. The two cases presented were both women in their reproductive
age with no significant risk factors for ovarian neoplasm. Squamous cell carcinoma arising in a
mature cystic teratoma is an aggressive type of carcinoma. Despite diagnosing as early as stage
I, a tumor recurrence may occur within a short interval of time. Although generally with a poor
prognosis, early detection is very important for better outcome. Surgery should be individualized,
depending on the stage and desire to preserve fertility. A close follow-up should be done
especially if a fertility-sparing procedure was done.
Introduction: Pseudo-Meigs’ Syndrome (PMS) is a rare disease characterized by the triad of (1)
an ovarian neoplasm, other than a fibroma or thecoma, (2) ascites, and (3) pleural effusion.
Tumors such as struma ovarii, mucinous and serous cystadenomas, and germ cell tumors have
been linked with the condition. Struma ovarii, known as ovarian goiter, is a specialized mature
teratoma derived from germ cell layers wherein thyroid tissue (>50%) has predominantly
overgrown other elements. Due to its clinical features combined with the elevation of serum
cancer antigen 125 (CA- 125) levels, it is often mistaken and treated as a malignant ovarian tumor.
Despite its presentation, this entity has an excellent prognosis when surgical excision of the
tumor is performed.
Course of the Patient: Presented is an unusual case of a 41-year-old G10P10 (10-0-0-9) who was
diagnosed as a case of struma ovarii associated with pseudo-Meigs’ syndrome, a concomitant
abdominopelvic tuberculosis and a fourth degree pelvic organ prolapse. Initial consideration of
a malignant tumor was based on the history, physical examination and imaging findings. With
the peritoneal fluid cytology finding of the presence of acid-fast bacilli, Anti-Koch’s regimen was
initiated for 1 month before performing the definitive surgical procedure of exploratory
laparotomy, total hysterectomy with bilateral salpingo-oophorectomy with staging procedure,
appendectomy, Halban culdoplasty, uterosacral fixation under continuous lumbar epidural
anesthesia. The post-operative course was uneventful. Six months of anti-Koch’s regimen was
completed with resolution of the ascites and pleural effusion.
Discussion: Increasing awareness in the occurrence of benign complex pelvic masses which
mimic malignant conditions is essential in arriving at a correct diagnosis. Thus, considering
pseudo-Meigs’ syndrome, doing confirmatory laboratory tests and imaging procedures, and an
intraoperative frozen section, could aid in accurately diagnosing and planning the surgical
management appropriate for the patient.
Introduction: Acute fatty liver of pregnancy (AFLP) is a unique liver disease in pregnancy that
warrants early detection and critical care management as it confers significant morbidity and
mortality in both mother and fetus. Prognosis depends on the severity, temporal development,
management, and complications arising from the disease. Management should be individualized
as to system affectation as there is currently no definitive treatment for this disease.
Course of the Patient: This is a case of a 33-year-old G5P5 (1405) admitted postpartum for loss
of consciousness. The patient was assessed to be drowsy, hypotensive, tachycardic, pale,
jaundiced and with epigastric tenderness. AFLP was highly considered. Laboratory results showed
severe anemia, leukocytosis, deranged bleeding parameters and elevated liver enzymes, serum
creatinine and bilirubin. The management required a multidisciplinary approach with careful
considerations regarding hemodialysis, blood transfusion, bleeding, multi-organ damage and
liver transplantation. The major issues that were encountered were the fulminant liver damage
and the persistently elevated serum creatinine. Daily hemodialysis was done to the patient and
with significant improvement observed.
Discussion: Pathogenesis of AFLP involves several inciting events with fatty acid oxidation and
deposition of harmful metabolites at its core. Treatment for AFLP is primarily directed at the
management of complications. This supports the notion that the accumulation of toxic long-chain
3-hydroxyl fatty acids (LCHA) metabolites in the maternal circulation may be the cause of liver
failure and associated sequelae; thus, removal of these metabolites brought significant
improvement. Despite the successful management of this case, there is still a paramount need
for a treatment protocol that will address the complex and severe presentation of this condition,
such as the need and timing for hemodialysis, appropriate blood transfusion vs. the severe
coagulopathy, and indication of liver transplantation for AFLP.
Keywords: acute fatty liver of pregnancy, fatty acid activation, liver transplantation
IC-34
Introduction: Gestational trophoblastic neoplasia (GTN) are uncommon malignant tumors that
mostly follow a molar pregnancy but can develop after any gestation. They are immensely
chemosensitive with excellent prognosis despite widespread metastases. Primary chemotherapy
with Methotrexate or Actinomycin is recommended for nonmetastatic and low-risk metastatic
disease. Chemoresistance or chemotoxicities may occur with either drug hence requiring a
subsequent treatment protocol. Etoposide-Actinomycin (EA) is an efficacious and well-tolerated
salvage therapy but there is paucity of data regarding its treatment experience.
Course of the Patients: This case series chronicles three patients diagnosed with low-risk
postmolar GTN. Case 1 is 23 years old, G2P1(1011), asymptomatic but with rising ß subunit of
human chorionic gonadotrophin (ß -hCG) titers while on outpatient monitoring. Case 2 is 18 years
old, G1P0 (0010) who consulted for hematuria; while Case 3 is 25 years old, G2P1(1011) who
consulted months after evacuation with her biopsy result but both did not comply with ß-hCG
surveillance. All three had unsuccessful primary and secondary chemotherapy, and were
switched to EA after considering the following attributes: ß-hCG < 60,000 mIU/mL at the time of
primary or secondary chemotherapy failure, minimal tumor burden, and no evidence of
metastases in other sites. Cases 1 and 2 achieved remission with the EA protocol with only mild
chemotoxicities. Both remain in remission and are doing regular ß-hCG surveillance at present.
Case 3 became chemorefractory to EA and had to be shifted to the fourth line regimen of
Etoposide, Actinomycin, Methotrexate, Cyclophosphamide, and Vincristine (EMACO). Then she
was lost to follow-up because of the COVID-19 pandemic, eventually had tumor progression and
succumbed.
Discussion: Resistance to the primary chemotherapy occurs in nearly 30-40% of low-risk
patients, but >90% will be cured by the use of sequential single-agent chemotherapy. In about
10% of cases, multi-agent chemotherapy with or without surgery to achieve remission will be
ultimately needed. EA is a reasonable second-line or third-line salvage regimen for selected
nonmetastatic and low-risk metastatic patients because it is simple, effective, safe, and
affordable.
Mellen Joy H. Villanueva, MD, Kathryn Kristy P. Bautista, MD, FPOGS, FPSMFM,
FPSUOG
Dr. Pablo O. Torre Memorial Hospital
Introduction: Uterine carcinosarcoma is a very aggressive and poor histologic type of cancer
comprising less than 5% of uterine malignancies. It primarily affects postmenopausal females.
However, the lowest age of presentation at 15-17 years old has also been reported. The overall
outcome remains poorly understood. A comprehensive surgical staging procedure is
recommended.
Course of the Patient: This is a case of a 15-year-old nulligravid with menarche at 13 years. Five
months prior to presentation, the patient experienced prolonged heavy menses and a rapidly
growing vaginal mass. Transrectal ultrasound was suggestive of cervical pathology. Biopsy
showed embryonal rhabdomyosarcoma. Surgery was advised but the patient did not comply. In
the interim, the onset of dizziness and severe hypogastric pain prompted admission. On
examination, the patient was pale, hypotensive, tachycardic and tachypneic. Internal
examination showed a 20-cm prolapsing necrotic introital mass, solid and multilobular with
hemorrhagic areas. The patient underwent total abdominal hysterectomy with bilateral
salpingectomy. The prolapsed mass and uterus were transected vaginally, leaving behind the
barely identifiable cervix and fallopian tubes. The remainder of the specimen was removed
intraabdominally. Final histopathology showed uterine carcinosarcoma, stage IB.
Postoperatively, the patient had an unremarkable course, and subsequently underwent adjuvant
chemotherapy, with no recurrence noted for one year.
Discussion: Due to the rarity of the case, there is no standard management. No uniformly
defined staging criteria exist, and the International Federation of Obstetrics and Gynecology
(FIGO) recommend that staging be equivalent to endometrial cancer. An important clinical aspect
to note is the patient’s age, which is atypical for the disease. Age is an independent prognostic
factor, and older age is associated with poor prognosis.
Roxanne Gillea G. Tan, MD, Leo Francis N. Aquilizan, MD, FPOGS, FSGOP
St. Luke’s Medical Center, Quezon City
Introduction: Primary carcinoma of the vagina is rare and accounts for 1% of gynecologic
malignancies. Adenocarcinoma is the second most common primary cancer in the vagina.
Although less common than squamous cell carcinoma, it represents 15% of all primary vaginal
malignancies. The most common manifestation of this malignancy is vaginal bleeding. Specific
criteria in establishing endometriosis-related malignancy as presented by Sampson include the
presence of benign endometrial and malignant tissue at the same site, the presence of
endometrial stroma surrounding glands, and the exclusion of metastasis from another primary
site.
Course of the Patient: This is a case of a 63-year-old G1P1 (1001), who presented with
postmenopausal bleeding. She had a history of total abdominal hysterectomy and bilateral
salpingo-oophorectomy for endometriosis 20 years ago. A 3-cm vaginal mass was appreciated on
internal examination. Vaginal stump biopsy and immunohistochemical stains revealed vaginal
endometrioid adenocarcinoma. Positron emission topography (PET) scan showed no metastasis;
hence, surgical intervention was advised. The patient underwent peritoneal fluid sampling,
excision of vaginal mass, vaginectomy, bilateral lymph node dissection, omentectomy under
combined regional – general anesthesia where in histopathology revealed vaginal endometrioid
adenocarcinoma, grade III.
Discussion: Primary endometrioid adenocarcinoma of the vagina is the second most common
subtype of vaginal adenocarcinoma and accounts to 8-10% of cases. In majority of cases, it is
seen in association with endometriosis, which is a finding that helps in the exclusion of metastatic
disease. Treatment of vaginal carcinoma depends primarily on histology, tumor volume,
anatomic location, stage, and age of the patient. The origin, natural history, malignant
transformation, and laboratory management of endometriosis are not yet clearly investigated.
Strategies for prevention, early detection, specific diagnosis, and treatment should be set up
targeting the pathogenesis of endometriosis to better understand endometriosis-associated
cancer.
Marie Felle P. Flores, MD, Angelito D.L. Magno, MD, FPOGS, FSGOP
De La Salle University Medical Center
Introduction: Primary signet ring cell carcinoma of the ovary and the cervix is rare and is most
commonly metastatic from a primary lesion. Discerning between primary and metastatic signet
ring cell carcinoma of the ovary or cervix may be difficult.
Course of the Patient: This is a case of a 37-year-old nulligravid, who presented with increased
abdominal girth with associated abdominal pain. Initial impression was ovarian new growth,
probably malignant, and cervical mass probably malignant. On laparotomy, intraoperative
impression was cervical with ovarian malignant tumor, primary unknown vs. double primary.
Histopathology revealed metastatic adenocarcinoma, right ovary, cervical stroma, omentum and
umbilical mass with anterior abdominal mass. Peritoneal fluid was positive for malignant cells.
On further work up, immunohistochemical stains CK7, CK19, CK20, and CDX2 tested positive in
tumor cells and were noted to be consistent with metastatic carcinoma of gastric vs. pancreatic
primary. Further work-up was done and the biopsy from the esophagogastroduodenoscopy
revealed poorly-differentiated adenocarcinoma with signet ring features, antral mucosa.
Discussion: Gastric cancer is the fifth most frequently diagnosed cancer and the fourth cause of
cancer death worldwide. Studies have shown that the incidence of signet ring cell carcinoma
subtype has been increasing. Diffuse-type gastric carcinoma, referred to signet ring cell
carcinoma has presence of signet ring cells and has poorly cohesive single cells with no gland
formation. Signet ring cell carcinoma is more frequent in women as compared to non-signet ring
cell carcinoma. It occurs among younger patients, with age ranging from 55 to 61 years. It
commonly arises in the stomach. Common metastatic sites are liver, lung, bone, and lymphatics
while gynecologic organs are not common metastatic sites. A thorough clinical history and
physical examination paired with diagnostic modalities may be able to aid in arriving at the
correct diagnosis.